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ABSTRACT OF DISSERTATION

AN INVESTIGATION ON THE EFFECTS OF INFLUENZA VIRUS INFECTION AS IT
PERTAINS TO THE INITIATION OF TRANSLATION

Like the majority of host cell mRNAs, the mRNAs of influenza virus are capped
and polyadenylated. The NS1 protein of influenza has been implicated as a
translational activator for both influenza and reporter gene mRNAs. Data is presented
showing that influenza A virus infection resulted in an increased ratio of cap-dependent
to cap-independent translation. This ratio increase was largely due to an increase in
cap-dependent translation. These experiments employed a bicistronic reporter
construct measuring cap-dependent and cap-independent translation in a single
sample. Expression of NS1 alone resulted in a small, but reproducible increase in the
ratio of cap-dependent to cap-independent translation. Additionally, with use of an NS1
deleted mutant influenza A virus (delNS1) it is shown that infection without NS1
expression produced less of a translation ratio increase compared to wild-type virus
infection. Furthermore, expression of NS1 rescued a more wild-type ratio increase in
delNS1 infected Vero cells. These results implicate NS1 as playing a role in increasing
the ratio of cap-dependent to cap-independent translation in influenza A virus infected
cells. Additionally, eIF4E-binding protein-1 (4E-BP1), a member of the protein

family that inhibits cap-dependent translation through their inhibition of the cap-binding
protein, eukaryotic initiation factor 4E (eIF4E), is shown to be inactivated throughout the
majority of the influenza A virus infection process.
KEYWORDS: Influenza virus, Cap-dependent translation, Cap-independent translation,
NS1, IRES.
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Chapter 1: Introduction
Influenza A virus summary
Influenza virus is consistently one of the most devastating communicable
diseases plaguing the worldwide human population. Each year in the United States
over 100,000 people are hospitalized for influenza infection. Additionally, on average
30,000 people die each year in the U.S. resulting from complications of influenza
infection (Simonsen et al., 2000; Thompson et al., 2003). Pandemics of influenza
periodically sweep the world, infecting anywhere from 20%-40% of the total human
population (Cox & Subbarao, 2000). These pandemics are theorized to occur due to
the emergence of influenza virus strains with novel Hemagglutinin (HA) proteins for
which people have no antibodies and are immunologically naïve (Kilbourne, 1977). The
most notable pandemics known to have occurred are those of 1890, 1918, 1957 and
1968 (Reid & Taubenberger, 2003). Of these, the 1918 “Spanish Flu” has gained the
most notoriety as a result of its unusually high mortality rate and young target
population. The flu of 1918 was typical in that most of the case morbidity was specific
to those under the age of 15 (Jordan, 1927). However, highly unusual was the high
mortality rate of those under the age of 65 (Linder, F. E. and Grove, R. D., 43). Of the
influenza-associated deaths of the 1918 virus, generally due to development and
complications of pneumonia, 99% were people under the age of 65. Even more
surprising was that people between the ages of 20 and 40 years were those most
affected (Simonsen et al., 1998). Previous pandemics have generally occurred in 10-20
year intervals, however it has now been 36 years since the last such pandemic. Thus, it
is theorized we are currently due for another such large-scale outbreak. Recent
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predictions as to the severity of the next pandemic are dire. It is estimated that in the
U.S. alone there will be up to 207,000 deaths, 734,000 hospitalizations, 42 million
outpatient visits and 47 million additional illnesses. With this in mind and the estimated
economic impact of 70-170 billion dollars, excluding disruptions to commerce and
society, influenza virus poses a major threat to the world community as a whole (Meltzer
et al., 1999).
Influenza A virus is one of five members of the Orthomyxoviridae family of
viruses (Lamb & Krug, 1996). The other members of this virus family are influenza B
virus, influenza C virus, thogotovirus and isavirus. All viruses in this family are
characterized as having a segmented, single stranded, negative sense RNA genome.
There are three known types of influenza virus: A, B and C. Under electron microscopy
(EM) influenza C is distinguishable from its two cousins owing to its hexagonal
glycoprotein arrangement. However, types A and B share such similar morphology they
are indistinguishable under EM (Flewett & Apostolov, 1967; Herrler et al., 1981;
Waterson et al., 1963). Influenza A and B viruses also exhibit very pleomorphic
morphology when isolated from humans or animals and passaged only once in culture.
When these viruses are regularly passaged in culture they take on a much more regular
shape and size (Horne et al., 1960; Hoyle et al., 1961). Viruses of all three influenza
types consist of a segmented negative sense RNA genome lined with nucleoprotein
(NP) and encapsidated within a shell of matrix protein (M1). The capsids are
enveloped by a host cell membrane derived lipid layer. The genomes of both types A
and B consist of 8 total genomic RNA segments where as the genome of type C
consists of only 7, due to its dual-function hemagglutinin-esterase-fusion (HEF)
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glycoprotein. Thus, unlike influenza A and B viruses, which have two surface
glycoproteins, HA and neuraminidase (NA), protruding from their envelopes, influenza C
virus has only one surface glycoprotein which alone appears to perform functions
similar to both the HA and NA (Herrler et al., 1988; Herrler & Klenk, 1991; Herrler et al.,
1988; Herrler et al., 1981; Herrler et al., 1987; Herrler et al., 1985a; Herrler et al., 1985b;
Rogers et al., 1986; Vlasak et al., 1987).
Of these three influenza types, A and B are the most common causes of
outbreaks, with type A causing the majority of the infections (Simonsen, 1999). It is
thought that due to its much larger host range including humans, swine, equids and a
variety of water fowl, influenza A virus has a greater propensity for causing devastating
outbreaks in the human population. Influenza B virus is a major cause of respiratory
illness in humans. However, it appears to almost exclusively infect humans, although
seals are a newly discovered host (Baine et al., 1980; Osterhaus et al., 2000). This
dramatically reduces influenza B virus’ potential for genetic diversity through a process
of genetic exchange with viruses of differing host species. Influenza A virus differs in
that it is presumed to be largely an avian virus, which replicates asymptomatically in the
intestines of aquatic birds. Distinguishing the subtypes of influenza A virus are the two
major antigenically significant proteins, HA and NA, of which there are currently 15 and
9 subtypes classified respectively (Webster et al., 1992; Webster et al., 1978). Of these
subtypes, only a few (H1, H2, H3, H5, N1, N2) are known to infect humans. However,
due to the susceptibility of pigs to some subtypes of both avian and human influenza A
viruses, it is theorized that pigs are an intermediary for genetic reassortment between
avian and human viruses in dually infected animals. This idea was first conjured in
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1985 as a result of experiments analyzing the impact of viral NP protein on host
specificity of ts mutant influenza A virus (Scholtissek et al., 1985). These suspicions
were confirmed in 1992 when a phylogenetic study was performed comparing influenza
A virus genomes isolated from avians, humans, and swine in Italy (Castrucci et al.,
1993). The theory is that in a dually infected cell the two virus genomes may reassort
with each other to produce novel combinations of gene segments, essentially
generating a hybrid virus. Pigs are susceptible to both human and avian influenza
viruses because of the terminal sugar linkages on the glycoprotein receptors of their
tracheal epithelium. In humans, sialic acids of these receptors tend to be linked to a
galactose by an α2,6 configuration, whereas in avians, the terminal sialic acid linkages
are α2,3. Since pig sialic acids are found linked in both configurations, influenza viruses
of both avian and human origin are capable of binding (Ito et al., 1998). Such virus
promiscuity greatly enhances influenza A virus’ power for genetic diversity and therefore
survival.
Until 1997 it was thought humans could not be directly infected with an avian
virus without going through a reassortment event in an intermediary host. However,
during the 1997 Hong Kong outbreak 18 people were infected, of whom 6 died, with a
completely avian influenza A virus (H5N1) (Lin et al., 2000). This incident proved that
humans are not only at risk from viruses reassorted through intermediary hosts, but also
from viruses through direct transmission from an avian reservoir. The Hong Kong virus
of 1997 was particularly virulent because of its resistance to interferons alpha and
gamma (IFN-α and IFN-γ) and tumor necrosis factor alpha (TNF-α), cytokines usually
effective against influenza A virus replication. This resistance was conferred by the
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H5N1 virus’ non-structural (NS1) protein, one of influenza A virus’ 10 proteins (Seo et
al., 2002). This was discovered in an experiment where replacement of the H5N1 NS1
gene with that of a cytokine susceptible virus conferred a loss of resistance.
The influenza A virus genome consists of 8 segments which code for 10 proteins,
all of which play essential roles during virus infection of normal hosts. Of the influenza
proteins, 9 are present in the structure of the mature virion and 1, NS1, is present only
in the infected host cell. Of the proteins present in the virion, the HA and NA are the
two antigenic surface proteins against which the host mounts its primary antibody
response (Laver & Valentine, 1969). The HA exists as a homotrimer, which during an
infection binds to sialic acid glycoprotein receptors on the surface of the host cell and
also mediates the virus/endocytic vesicle membrane fusion (White et al., 1981; Wiley &
Skehel, 1977; Wiley et al., 1977; Wiley et al., 1981). The NA cleaves terminal sialic acid
and terminal D-galactose or D-galactosamine structures and appears to be important in
preventing the virus from self-aggregating, as well as from re-adsorption to the producer
host cell (Gottschalk, 1957). These two surface proteins are anchored to a lipid bilayer
derived from the cell membrane during egression from the host cell. Within this lipid
layer also exists an ion channel protein formed by tetramers of the M2 protein, which is
key in uncoating the genome during virus entry (Holsinger & Lamb, 1991; Sugrue &
Hay, 1991). Beneath the lipid layer is a sheet of M1, which surrounds the viral
ribonucleoprotein (vRNP) genome (Gregoriades, 1973; Lamb et al., 1985). The vRNPs
are characterized as single genomic segments wound with a protective coat of the NP
protein and complexed with the three polymerase proteins: PB1, PB2 and PA (Inglis et
al., 1976; Lamb & Choppin, 1976). The nuclear export protein (NEP), formerly NS2,
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was first thought to be a nonstructural protein present only in the infected host cell,
however it is now thought that NEP is present in the virion and plays a role in the
nuclear to cytoplasmic export of vRNPs during virion assembly (O'Neill et al., 1998;
Richardson & Akkina, 1991; Yasuda et al., 1993). The 10 total proteins coded for by
influenza A virus are transcribed from 8 full length mRNA transcripts and 2 alternatively
spliced transcripts, which code for NEP and M2 (Inglis & Brown, 1981; Lamb et al.,
1980). As will be described in more detail later, during an infection the nonstructural
protein, NS1, plays a crucial role in shutting down the nuclear to cytoplasmic export of
cellular mRNAs, as well as inhibiting the activation of the antiviral interferon cascade.
Once the virion has bound to a sialic acid glycoprotein receptor through HA
interaction, the virus is endocytosed into the host cell. At this point the virus is enclosed
and anchored to the interior membrane of the endosome. In the late endosome the pH
decreases, resulting in a conformational change of the HA which leads to fusion of the
virion and endosomal membranes which releases the viral genome in the form of
vRNPs. The low pH of the endosome is crucial for activating the M2 ion channel, which
then allows for the flow of protons from the endosome into the virion. It is thought this
flow of protons is essential for disrupting the viral capsid and releasing the genomic
segments into the cytoplasm. Treatment with amantadine, an M2 channel inhibitor,
leads to the failed dissociation of M1 from the vRNPs (Martin & Helenius, 1991).
These vRNPs are then directed to the nucleus where the negative sense RNA is
transcribed into mRNA as well as full length, positive sense template for genome
synthesis. Even though influenza virus particles incorporate their own RNA-dependent
RNA polymerase complexes (PB1, PB2 and PA), it was observed that inhibition of the

6

cellular RNA polymerase II protein inhibited viral replication (Lamb & Choppin, 1977;
Mahy et al., 1972; Spooner & Barry, 1977). These observations are explained by the
current model for influenza A virus transcription, in which capped cellular mRNA
fragments are used as primers for viral mRNA synthesis (Bouloy et al., 1979; Bouloy et
al., 1978). Inhibition of RNA polymerase II reduces the supply of capped mRNAs
necessary for influenza A virus transcription and therefore, replication. The complex of
PB1, PB2, PA, attached to vRNA and NP binds cellular mRNA via PB2’s interaction with
the 5’ cap structure (Blaas et al., 1982; Braam et al., 1983; Ulmanen et al., 1981). This
interaction appears to be independent of any base pairing between the cellular mRNA
and the vRNA (Krug, 1981; Krug et al., 1980), which would explain the ability of the
polymerase proteins to utilize the heterogeneous assortment of cellular mRNAs as
primers. According to UV-cross-linking experiments, the PB1 protein is found as the
leading protein of the polymerase complex and is likely responsible for nucleotide
addition onto the growing viral mRNA (Braam et al., 1983). Additionally, PB1 is also
thought to be responsible for the cap-dependent cleavage of the cellular mRNA primer,
approximately 10-12 nucleotides down-stream of the cap structure, from the remaining
cellular pre-mRNA (Li et al., 2001a). The role of the PA protein is not as well defined as
the roles of PB1 and PB2. However, it has been suggested that the PA protein is
essential in the transcription of complementary and genomic vRNA (Honda et al., 2002;
Nakagawa et al., 1996).
Following transcription of mRNA and the synthesis of viral proteins, a switch from
mRNA transcription to genomic replication occurs in influenza A virus infected cells
(Barrett et al., 1979; Hay et al., 1982). It is likely that this RNA transcription switch is
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regulated by viral protein synthesis, as the existence of free NP proteins is necessary
for the transcription of complementary RNA (cRNA) as well as the genomic vRNA
(Beaton & Krug, 1986; Shapiro & Krug, 1988). Although the mechanism for this
requirement is not fully understood, it is presumed that the transcription process of
cRNA and vRNA is dependent on their association with NP. Taken together, it has
been postulated that there exist two separate polymerase complexes in the infected
cell: one free of PA, which would be used for mRNA synthesis, and one complexed
with PA for cRNA/vRNA synthesis {#2990}. However, this theory has yet to be
adequately studied and the true arrangement of the polymerase complex in vivo is not
precisely understood. It should be noted the simplest complex needed for replication of
a pseudo-genomic reporter construct, which contains influenza 5’ and 3’ terminal
sequences is PB1, PB2, PA and NP (Huang et al., 1990).
Cap-dependent translation initiation
The initiation of translation has proven to be a highly regulated process in protein
synthesis and its inhibition could be a point from which viral infections can be quashed
(Sonenberg, N., Hershey, J. W. B., and Mathews, M. B., 2000). To summarize, during
the initiation step the mRNA is loaded onto the 40S subunit of the ribosomal machinery,
which then scans down the mRNA in a 5’ to 3’ direction until it locates the initiating AUG
start codon (summarized in Fig. 1). The large ribosomal subunit is then recruited to the
complex and elongation of the peptide continues. In eukaryotic systems the mRNA can
be loaded onto the small ribosomal subunit through a cap-dependent mechanism or a
cap-independent mechanism. In cap-dependent initiation the mRNA is loaded via the
methyl-7-GTP cap structure located at the 5’ end of the mRNA.
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Cap-dependent initiation begins with the formation of the ternary complex:
methionyl-tRNAi (Met-tRNAi), eIF2 and GTP. Once the ternary complex has been
formed it can then bind to the 40S ribosomal subunit. The resulting complex is often
called the preinitiation complex or the 43S complex. It is known that preinitiation
complex formation may occur in the absence of mRNA binding {#1240}. The methyl-7GTP cap structure of the mRNA is then bound to a member of the translation initiation
complex termed eukaryotic initiation factor 4F (eIF4F). eIF4F is composed of three
protein factors: eIF4E, the cap binding protein; eIF4G, a scaffolding protein; and eIF4A,
a helicase.
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Figure 1. Summary of cap-dependent initiation of translation. A. Dissociation of ribosome. B.
Formation of ternary complex and 43S pre-initiation complex. C. mRNA binding to pre-initiation
complex. D. Binding of large ribosomal subunit.
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Each of the three components of the eIF4F complex has a specific function as it
pertains to the initiation of translation. The cap binding protein, eIF4E, specifically binds
to the 5’ cap of the mRNA and links it to the initiation complex (Sonenberg et al., 1978).
There have been numerous forms of eIF4E found in various species, including two in
humans (Rom et al., 1998). However, the purpose of these various forms is unknown.
Although eIF4E alone is capable of binding capped mRNA, when complexed with
eIF4G, eIF4E is able to bind capped mRNA with 10-fold greater affinity (Haghighat &
Sonenberg, 1997). The physical binding between eIF4E and the 5’ cap is done through
intercalation of the m7G ring into a stacked set of two highly conserved tryptophan
residues (Marcotrigiano et al., 1997; Matsuo et al., 1997). eIF4E is phosphorylated at
serine 209, using mammalian eIF4E amino acid numbering, by the kinases Mnk1 and
Mnk2 (Knauf et al., 2001; Waskiewicz et al., 1997). How this phosphorylation affects
translation has yet to be definitively explained; although, frequently increased
phosphorylation at this site coincides with higher levels of translation (Scheper & Proud,
2002). eIF4E phosphorylation has been linked to the down-regulation of cap-dependent
translation, and furthermore, expression of a non-phosphorylatable mutant eIF4E
partially reverses this effect (Knauf et al., 2001). However, another group has recently
presented contradictory data, that dephosphorylation of eIF4E results in an increase in
cap-independent translation (Dyer et al., 2003). eIF4E has been shown to be
dephosphorylated during influenza infection (Feigenblum & Schneider, 1993).
However, it is unclear how this dephosphorylation affects virus replication because of
the uncertainty in how phosphorylation regulates eIF4E function. As stated previously,
although high phosphorylation of eIF4E has often been found during times of high
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translation, a cause and effect relationship has been difficult to establish.
Saccharomyces cerevisiae lacking functioning endogenous eIF4E can be rescued for
growth as efficiently by mutant, non-phosphorylatable eIF4E as the wild-type protein
(McKendrick et al., 2001). Interestingly, a mutant strain of Drosophyla melanogaster
expressing only non-phosphorylatable eIF4E has been found viable. The only major
phenotypic difference found between these mutant flies and their wild-type counterparts
is a smaller body size. Surprisingly, the mutant flies maintain a wild-type cell count as
well as body proportion when compared to wild-type flies. It appears their smaller body
size is simply due to smaller individual cell size (Lachance et al., 2002).
In addition to phosphorylation, eIF4E is regulated through interaction with the
eIF4E-binding proteins (4E-BP). When eIF4E is bound to 4E-BP it is sequestered from
the initiation complex and therefore cannot play its part in initiating cap-dependent
translation (Haghighat et al., 1995). The 4E-BPs are regulated through a
phosphorylation hierarchy, whereby hypophosphorylation results in eIF4E binding and
hyperphosphorylation results in eIF4E release (Fadden et al., 1997; Gingras et al.,
1999; Lin et al., 1994; Pause et al., 1994). This is to say that when 4E-BP is highly
phosphorylated cap-dependent translation is maintained at high levels, and conversely,
when 4E-BP is under-phosphorylated cap-dependent translation is decreased.
The 4E-BPs are a group of proteins made up of three members, termed 4E-BP1,
2 and 3, which all share greater than 55% amino acid homology with one another
(Pause et al., 1994; Poulin et al., 1998). Interestingly, the three members of the 4E-BPs
are expressed at different levels depending on the cell type (Hu et al., 1994; TsukiyamaKohara et al., 1996). This hints at the possible evolution of different isoforms for
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different tissues and/or functions. As stated above, the 4E-BPs bind to eIF4E and
prevent it from associating with the initiation complex, specifically to eIF4G. This
association with eIF4E is conferred by a conserved binding sequence motif “YXXXXLΦ”
in which X is any amino acid and Φ is an aliphatic amino acid, usually L but sometimes
M or F (Altmann et al., 1997; Mader et al., 1995). 4E-BP1 is regulated through a
complex hierarchy of phosphorylation events at six known sites and this regulation is as
yet not fully understood. There are two phosphorylation sites, Thr-37 and Thr–46,
which are located on the amino-terminus of the protein and are generally found
phosphorylated during times of serum starvation in cell culture. Upon addition of serum,
phosphorylation of these sites is only moderately increased (Gingras et al., 1999). This
is in contrast to Ser-65 and Thr-70, which are located at the carboxy-terminus of the
protein and are found dephosphorylated or weakly phosphorylated during serum
starvation in cell culture. However, upon addition of serum, phosphorylation at these
two sites is greatly increased (Gingras et al., 1999; Gingras et al., 1999). The current
model is that the two “priming” sites, Thr-37 and Thr-46, are phosphorylated by the
kinase FRAP/mTOR, a rapamycin sensitive kinase (Burnett et al., 1998; Gingras et al.,
1999). Ser-65 and Thr-70 are phosphorylated by a kinase, or set of kinases, activated
by the Akt/PKB kinases (Gingras et al., 1998; Kohn et al., 1998). The Akt/PKB kinases
are activated via a PI3 kinase pathway and whether Akt/PKB activation affects
FRAP/mTOR activation is not yet fully defined (Nave et al., 1999; Sekulic et al., 2000;
West et al., 2002). Two other phosphorylation sites, Ser-83 and Ser 112, are not well
understood and their phosphorylation may be cell line specific (Fadden et al., 1997;
Fadden et al., 1998; Gingras et al., 1999; Gingras et al., 1998; Gingras et al., 1999;
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Heesom et al., 1998). 4E-BP2 and 3 both maintain all the possible phosphorylation
sites as 4E-BP1 except Ser112. However, not all of these remaining sites on 4E-BP2
and 3 are found phosphorylated in vivo. It is unclear how these phosphorylation
patterns differ functionally from one another and how these differences may affect their
function in vivo.
The scaffolding protein, eIF4G, of which there are two forms, eIF4GI and
eIF4GII, seems to play the role of an adapter molecule for the eIF4F complex (Gradi et
al., 1998; Yan et al., 1992). The two forms of eIF4G share 46% identity and function as
homologs (Gradi et al., 1998). Through its multiple binding capabilities, eIF4G
physically bridges the small ribosomal subunit to eIF4E via its interaction with another
initiation factor, eIF3. The amino terminal portion (amino acids 1-634) of eIF4GI is
responsible for binding eIF4E as well as poly(A)-binding protein (PABP) and is required
for cap-dependent translation (Imataka et al., 1998; Lamphear et al., 1995; Mader et al.,
1995). During picornavirus infections the amino terminus of eIF4GI is cleaved rendering
it unable to bind to eIF4E (Lamphear et al., 1993). This cleavage, although abolishing
cap-dependent translation, does not affect the translation of viral mRNAs, which are
translated in a cap-independent manner through IRES initiation. The middle portion of
eIF4G, residues 635-1039, contains binding sites specific to eIF4A, eIF3 (Imataka &
Sonenberg, 1997) and RNA (Pestova et al., 1996). The carboxy-terminus has binding
sites for a second eIF4A (Imataka & Sonenberg, 1997) as well as the kinases Mnk1 and
Mnk2 (Pyronnet et al., 1999), both of which have been implicated in eIF4E
phosphorylation (Knauf et al., 2001; Waskiewicz et al., 1997). eIF4G is also a
phosphoprotein, however, the pathways involved in its phosphorylation and the
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functional effects imposed on eIF4G are poorly understood (Bu et al., 1993; Donaldson
et al., 1991; Feigenblum & Schneider, 1993; Morley & Pain, 1995a; Morley & Pain,
1995b; Morley & Traugh, 1990; Morley & Traugh, 1993; Tuazon et al., 1989).
Interestingly, a physical interaction has been found between eIF4G and the influenza A
virus NS1 protein (Aragon et al., 2000). How this association might affect virus
replication is, however, not understood. A third member of the eIF4G family, p97, also
known as NAT1 or DAP-5, is a protein homologous only to the carboxy-terminal twothirds portion of eIF4GI and II (Imataka et al., 1997; Levy-Strumpf et al., 1997;
Yamanaka et al., 1997). p97 appears to maintain all the eIF4G functions to which it is
homologous, in that it can bind eIF4A, eIF3 and Mnk1. Additionally, p97 inhibits capdependent translation, presumably through its interaction with eIF4A and eIF3 to form
inactive initiation complexes (Imataka et al., 1997).
The ATP dependent helicase, eIF4A, is important in unwinding the secondary
structure of the mRNA’s 5’ untranslated region (UTR) (Lawson et al., 1988). mRNA
containing a highly structured 5’ UTR, i.e. with multiple intra-chain base pairings to form
stem-loop secondary structures, would prove difficult for ribosomal scanning and the
need for eIF4A activity becomes apparent. Hypothetically, eIF4A activity becomes a
potential player in the translation regulation of highly structured mRNAs; whereby higher
eIF4A activity confers higher protein expression from those mRNAs. The opposite
would also be true in that by decreasing eIF4A activity a decrease in protein expression
from highly structured mRNAs would be observed. Two initiation factors, eIF4B and
eIF4H, have been found to increase the ability of eIF4A to unwind the secondary
structure of mRNA (Jaramillo et al., 1991; Richter-Cook et al., 1998; Rozen et al., 1990).
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eIF4A is not processive, this is to say that eIF4A is capable of unwinding only 3-5 base
pairs at a time without the assistance of eIF4B or eIF4H (Lorsch & Herschlag, 1998a;
Lorsch & Herschlag, 1998b; Rogers et al., 1999). It is thought that through their
interaction with RNA, eIF4B and eIF4H are able to prevent the reassociation of
unwound RNA and therefore to promote the unwinding action of eIF4A.
Cap-independent translation initiation
In contrast to cap-dependent initiation, cap-independent initiation does not
require the cap binding protein, eIF4E. Therefore, regulation inhibiting the activity
eIF4E does not affect the initiation of cap-independent messages. Cap-independent
messages are recruited to the initiation complex through sequence elements in the 5’
UTR of the mRNA that are termed internal ribosome entry sites (IRES) (Belsham &
Jackson, 2000). IRES, initially discovered in picornaviruses, are characterized as RNA
sequences with a predicted high level of secondary structure (Pelletier & Sonenberg,
1988). It appears that through widely diverse and ill understood binding mechanisms,
this secondary structure is essential for the mRNA’s interaction with the ribosome.
Therefore, IRES obviate the role of eIF4E and the 5’ cap in translation initiation. Such is
observed in many picornaviruses when early in infection eIF4G is cleaved, leaving
eIF4E without its adapter to the ribosome (Etchison et al., 1982; Lee et al., 1985).
Interestingly, most of the picornaviruses need the remaining initiation factors other than
eIF4E for translation initiation (Imataka & Sonenberg, 1997; Lamphear et al., 1995;
Pestova et al., 1996; Pestova et al., 1996). IRES are very diverse in their sequence,
structure and effector protein binding and therefore, it should be understood that IRES
characterization is still in its early stages. In recent years many eukaryotic mRNAs have
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been identified, which are thought to contain IRES elements within their sequences.
However, the existence of eukaryotic translation initiation through IRES has been
questioned (Kozak, 2001). In her commentary, Kozak cites deficiencies in much of the
current work claiming identification of eukaryotic IRES. In her opinion she describes
poorly designed controls as well as faulty interpretations. Dr. Kozak describes the
possibility of cryptic promoters and alternatively spliced mRNAs rather than true IRES to
account for many investigators’ observations. However, in defense of their work many
in the field of IRES translation submitted a response to Dr. Kozak’s criticisms
(Schneider et al., 2001). The number of reports supporting IRES translation in
eukaryotic cells far out number those questioning it. It is presumed that IRESdependent mRNAs code for proteins important during periods where cap-dependent
translation is shut down. Possible eukaryotic mRNAs translated in a cap-independent
manner include, but are not limited to, mRNAs coding for proteins affecting apoptosis,
translation, growth stimulation and RNA processing. In an analysis of 7000 cellular
mRNAs, 200 were found associated with polysomes under conditions of total or near
total eIF4G cleavage (Johannes et al., 1999). A web-based database for suspected
IRES, both viral and cellular, is now available at
http://ifr31w3.toulouse.inserm.fr/IRESdatabase/.
Presumably, stressed cells undergo the process of apoptosis in an attempt to
minimize the damage done on neighboring tissues. Studies on cap-independent
translation have begun to assess its importance in the cellular response to various
stresses leading to apoptosis. It has been shown that many viral infections, including
that of influenza A virus, result in apoptosis (Lin et al., 2002; Takizawa et al., 1993).
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One of the hallmarks of apoptosis is the cleavage of eIF4G by activated caspase-3
(Marissen & Lloyd, 1998). This cleavage is reminiscent of the cleavage resulting from a
picornavirus infection, although their cleavage profiles are different. Considering that
cleavage of eIF4G favors cap-independent over cap-dependent translation in
picornavirus infections (Imataka & Sonenberg, 1997; Lamphear et al., 1995), it is
possible that caspase-3 cleavage of eIF4G during apoptosis also enhances capindependent translation. Reports of cap-independent translation in apoptotic cells are
conflicting. Interestingly, in one report, it appears that opposing factors involved in proand anti-apoptotic stimulation can both be translated in a cap-independent manner. In
these studies reporter genes were put under the translational control of the IRES of
different apoptotic factors. A reporter bearing the XIAP IRES is actively translated
during conditions of transient cellular stress, such as serum starvation or low doses of
γ−irradiation (Holcik et al., 1999; Holcik et al., 2000). Similarly, under another mild
stress, anoxia, reporters bearing IRES from two pro-apoptotic factors, Apaf-1 and
DAP5, can also be translated, though to a much lower magnitude than the XIAP IRES
(Nevins et al., 2003). When treated with etoposide, a much stronger stress, translation
of the XIAP IRES is relatively low compared to the greater amount of translation driven
by the Apaf-1 and DAP5 IRES (Nevins et al., 2003). Results such as these suggest an
intricate system of regulation within the realm of cap-independent translation so as to
balance the cell’s interests for survival or death. More specifically, during times of
stress, when cap-dependent translation is inhibited, cap-independent translation directs
the expression of whichever factors are the most appropriate for the given situation.
Under light and likely transient periods of stress, it would benefit the cell to forgo
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apoptosis if recovery is likely, and for this to occur, regulation favoring the IRES driven
translation of anti-apoptotic factors would be necessary. However, if the stress were too
taxing for the cell to overcome, such as etoposide treatment, IRES driven translation
favoring pro-apoptotic factors would be appropriate. Unfortunately, and likely due to its
intricate and precise regulation, the data supporting such an idea are confusing as not
all reports agree on the finer details involved in cap-independent translation during
apoptosis. For example, Henis-Korenblit and colleagues observed an enhancement in
the translation driven by the XIAP IRES due to over expression of a particular eIF4G
family protein cleavage fragment, DAP5/p86 (Henis-Korenblit et al., 2002). Yet in one
of the previously mentioned studies, Nevins and colleagues found no such increase
(Nevins et al., 2003). However, the fundamental principle of cap-independent
translation being involved in the regulation of apoptotic factors during cellular stress
lends credibility to the investigation of cellular cap-independent regulation in other
circumstances, such as in the case of virus infection.
In addition to cell stresses, the position of cells in the cell cycle has been found to
affect the level of cap-independent translation. Ornithinine decarboxylase protein and
the 58 kDa PITSLRE protein kinase have been reported to be preferentially translated
by their IRES elements in the G2/M phase (Cornelis et al., 2000; Pyronnet et al., 2000).
Additionally, a viral IRES, from hepatitis C virus (HCV), has been reported to be most
active during the G2/M phase in HuH7 cells (Honda et al., 2000). Yet another report
finds the HCV and the encephalomyocarditis virus (EMCV) IRES are the least active
during the G2/M phase in HEK 293 cells (Venkatesan et al., 2003). Authors attribute
their differing results to the fact two different cell lines were used in these studies.
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These conflicting results support the idea that regulation of IRES driven translation is
very complicated and is tightly controlled. Such results also suggest a cell line/tissue
type-specificity relating to control of IRES driven translation. These specificities may
possibly be attributed to the differences found in the levels of canonical and
noncanonical translation factors found in individual cell lines.
The poliovirus IRES is one of the best studied IRES to date. Poliovirus is a
member of the picornaviridae family of viruses, which consists of 6 virus genera:
Enterovirus, Rhinovirus, Aphthovirus, Cardiovirus, Hepatovirus and Parechovirus.
Poliovirus, a member of the Enterovirus genera, like all picornaviridae is a nonenveloped positive sense RNA virus. Due to the positive sense nature of the viral
genome, the entire life cycle of the virus occurs within the cytoplasm of the host cell.
This was demonstrated by infection of enucleated cells (Follett et al., 1975). Since then,
much has been learned about the regulation and structure of the poliovirus, and other,
IRES. As was the case in cell cycle and cellular stress signaling, cell type also appears
to play a role in specific IRES translational activity. For example, a mutant virus
consisting of the capsid proteins of a poliovirus strain and the IRES sequence of a
rhinovirus loses replication efficiency in neuronal cells compared to the parental
poliovirus (Gromeier et al., 1996; Gromeier et al., 1999). However, both the parental
poliovirus strain and the mutant will replicate efficiently in HeLa cells. Such results
implicate a tissue tropism that is dependent specifically on the IRES encoded in the
genome. Again, as may be the case for the HCV and EMCV, since HeLa and neuronal
cells may express different levels of proteins involved in translational regulation, tissue
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tropism may be due to the availability of the appropriate cellular factors specifically
needed for translation from a particular IRES.
The poliovirus IRES (Fig. 2) is approximately 450 nucleotides in length and
although it was once thought the extreme 5’ end of the genome was only used to
regulate the RNA genomic replication, more recent evidence suggests that translation
efficiency can also be reduced following mutation of a stem-loop structure at position
21, well before the proposed IRES sequence (Gamarnik & Andino, 1998; Simoes &
Sarnow, 1991). At the 3’ end of the IRES is a sequence of approximately 25
nucleotides common to all picornaviruses, which begins with a tract of approximately 10
pyrimidines and ends with a G-poor sequence. The first AUG 3’ of this 25 nucleotide
sequence is considered the putative ribosomal entry site. However in the case of
poliovirus this first AUG 3’ to the IRES sequence, at position 586, does not appear to be
used at all (Ohlmann & Jackson, 1999; Pestova et al., 1994). Another AUG codon at
position 743, approximately 160 nucleotides down-stream appears to be the site of the
majority of all translation initiation (Dorner et al., 1982). Some have postulated that the
first AUG following the IRES may be a site of ribosome entry from which scanning
would then commence until a favorable AUG could be located (Belsham, 1992; Sangar
et al., 1987). However, the evidence for such a hypothesis is unclear because mutation
of the first AUG in the foot and mouth disease virus (FMDV), an Aphthovirus, IRES
results in only a slight decrease in the virus’ infectivity. Conversely, mutation of the
second, more efficient translation initiation site results in lethality (Cao et al., 1995).
Whether the ribosome may be able to enter the RNA at a non-AUG codon remains to
be studied. If so, a scanning hypothesis model could explain why mutation of the first
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AUG results in only a partial decrease in virus replication and mutation of the true
translation start codon is deleterious. More confusing are the results found in similar
mutational experiments using both type I and II poliovirus (PV-1, PV-2) IRES. The first
AUG 3’ of the PV-1 IRES, position 586, is required as mutation of it results in revertant
mutations introducing AUG codons near the original AUG at nucleotide 586 (Pilipenko
et al., 1992). However, mutation of the equivalent AUG in PV-2 IRES results in only a
slight decrease in plaque size phenotype in tissue culture and a slight reduction in IRES
driven translation (Meerovitch et al., 1991; Nicholson et al., 1991; Pelletier et al., 1988).
Additionally, in support of ribosomal scanning 3’ of the IRES, insertion of hairpin
structures between the two AUG codons results in reduced translation efficiency of
FMDV and PV-1 IRES (Belsham, 1992; Hellen et al., 1994; Lopez de Quinto &
Martinez-Salas, 1999; Pelletier & Sonenberg, 1988). However, it was noted the degree
of inhibition was less than expected with addition of such structures in a ribosomal
scanning model. Therefore, how the ribosome is recruited to the start codon is still
largely unknown.
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Figure 2. Diagram of the poliovirus IRES. (Belsham, G.J. & Jackson, R.J. (2000). Translation initiation
on picornavirus RNA. In Translational Control of Gene Expression, pp. 869-900. Edited by Sonenberg,
Hershey, and Mathews. Cold Spring Harbor, NY). Figure used with permission of publisher.

Additional cellular proteins have been found to enhance the translation driven by
some IRES sequences. The La protein was found to enhance the translation efficiency
of the PV-1 IRES in rabbit reticulocyte lysates (Meerovitch et al., 1993). However, the
concentration of La necessary for observing such increases is very high and its
physiological relevance for the PV-1 IRES has been challenged (Sonenberg, N.,
Hershey, J. W. B., and Mathews, M. B., 2000). During poliovirus infection La is
redistributed from the nucleus to the cytoplasm of infected cells, implying a role in
poliovirus IRES translation (Meerovitch et al., 1993). The polypyrimidine tract-binding
protein (PTB), a protein involved in RNA splicing, is another protein found to enhance
poliovirus IRES driven translation in rabbit reticulocyte lysates. However, this
stimulation is low in comparison to the PTB stimulation of the rhinovirus IRES
translation (Hunt et al., 1999; Hunt & Jackson, 1999). A cytoplasmic RNA binding
protein termed poly(rC) binding protein-2 (PCBP-2) has also been found to increase the
efficiency of translation from the poliovirus IRES. However, unlike the induction of La
and PTB, PCBP-2 appears to be a much better inducer of poliovirus IRES driven
translation. HeLa cell lysates depleted of PCBP-2 lose their capacity for poliovirus IRES
translation. Furthermore, addition of recombinant PCBP-2 to the depleted HeLa cell
extracts restores poliovirus IRES translation. Interestingly, depletion of PCBP-2 from
HeLa cell extracts had no effect on EMCV or rhinovirus IRES driven translation (Blyn et
al., 1997; Walter et al., 1999). Taken together these results illustrate the great diversity
in the mechanisms supporting cap-independent translation and a great deal of
investigation is needed for a more complete understanding of the system.
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Regulation of host cell translation during influenza A virus infection
The host cell has developed an assortment of defense mechanisms, which are
aimed at combating infectious agents. One mechanism in particular, which viral
infections are known to induce is an interferon (IFN) response. IFN can be separated
into two distinct categories: type I (α, β) and type II (γ). Type II IFN is commonly
secreted by Th-1 lymphocytes and NK immune cells. However, type I IFN are secreted
by a wide variety of cell types, including epithelial cells infected by influenza virus
(Barber, 2001; Basler & Garcia-Sastre, 2002). In a broad sense, both types of IFN work
to induce an antiviral state in activated cells. The most widely understood mode of type
I IFN activation during a viral infection is mediated by the production of double stranded
RNA. Double stranded RNA (dsRNA) is often an intermediate present in virus infected
cells and can be produced during viral genome transcription from an RNA template for
single stranded RNA viruses or from a double stranded RNA genome, as is the case for
reovirus. dsRNA induces the activation of many transcription factors known as IFN
regulatory factors (IRFs). IRFs are responsible for inducing the transcription of a variety
of genes containing IFN stimulated response elements (ISRE). Such genes include
PKR, 2’,5’-Oligoadenylate Synthetases/RNAse L and the Mx genes and are important in
bringing the cell into an antiviral state as well as alerting neighboring cells to do the
same. Additionally, dsRNA activation also leads to the production of more IFN, leading
to a positive feedback loop through autocrine stimulation (Basler & Garcia-Sastre,
2002). As may be expected, many viruses, including influenza A virus, have developed
strategies for impeding such antiviral counterattacks, which will be discussed later.
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Early during influenza infection, the host cell’s protein synthesis machinery is
assimilated and forced to selectively translate influenza mRNAs over their cellular
counterparts, and host encoded protein synthesis is effectively shut down. To date
there has been no identification of a single factor working to cause the host protein
synthesis shut-down. However, the NS1 protein has some functions that are pertinent
to translational control during an infection. NS1 enters the nucleus and shuts down the
polyadenylation and nuclear to cytoplasmic export of cellular mRNAs (Chen et al., 1999;
Li et al., 2001b). Subverting the host cell’s mRNA processing machinery is crucial for
the virus, because the initial interferon-α/β-independent IRF-3 and IRF-7 response
activates the transcription of antiviral pre-mRNAs coding for numerous effector
molecules (Kim et al., 2002; Navarro et al., 1998; Preston et al., 2001; Wathelet et al.,
1998; Weaver et al., 1998; Yoneyama et al., 1998), which would bring the cell into an
antiviral state. By the NS1 induced blockage of their processing, these antiviral premRNAs are never expressed. NS1 performs this block by binding to and inhibiting the
activities of both cleavage and polyadenylation specificity factor (CPSF) and poly(A)binding protein II (PABII); two host factors important in the 3’ processing of cellular premRNA (Chen & Krug, 2000; Chen et al., 1999; Li et al., 2001b; Nemeroff et al., 1998).
NS1 binds to both of these cellular proteins via its carboxy-terminal region, or what is
more commonly called the effector domain (illustrated in Fig. 3). The amino acid
regions of NS1 binding these cellular proteins are located in close proximity: CPSF
binds to amino acids centered around 186 and PAPII binds to the region between amino
acids 223-237 (Fig. 3) (Li et al., 2001b). Normally, during the processing of host premRNA into mature exportable message, CPSF binds to a specific signal sequence,
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AAUAAA, which is located upstream of the cleavage site in pre-mRNAs, and cleaves
the mRNA at that site making it ready for synthesis of a poly(A) tail by poly(A)
polymerase (PAP) (Colgan & Manley, 1997; Wahle & Kuhn, 1997). Once the premRNA has been cleaved at the 3’ end, PAP synthesizes the poly(A) tail through the aid
of PABII. By inhibiting CPSF, NS1 is able to abolish the addition of a poly(A) tail, a
process necessary for nuclear to cytoplasmic export. In addition to inhibition of CPSF,
NS1 also inhibits the processive elongation of the poly(A) tail by inhibiting the interaction
between PAP and PABII. Thus, NS1 inhibits polyadenylation, and nuclear export of
host mRNAs, through two different mechanisms.
NS1 Protein
Amino

Carboxy

1

73

186

232

237

CPSF binding domain
dsRNA binding and
dimerization domain

PABII binding domain

Figure 3. A schematic drawing of the influenza A virus NS1 protein

Expression of NS1 has also been shown to selectively increase the translation of
mRNAs bearing an influenza UTR as well as some co-transfected reporter genes
devoid of such sequences (Aragon et al., 2000; de la Luna et al., 1995; Enami et al.,
1994; Enami & Enami, 2000; Salvatore et al., 2002). By themselves, these actions of
NS1 do not account for the observed rapid reduction in host encoded protein synthesis.
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Furthermore, a mutant influenza virus devoid of NS1 expression is still able to induce a
host protein synthesis shut-down (Salvatore et al., 2002).
Recently a cellular protein factor has been identified which also increases the
translation of influenza mRNAs: guanidine-rich sequence factor 1 (GRSF-1). GRSF-1
is a member of the RNP superfamily of RNA binding proteins. These proteins are
characterized as containing one or more RNA recognition motifs (RRM), of which
GRSF-1 possesses three. The RRM is a conserved motif of approximately 80 amino
acids with two highly conserved regions. This superfamily of proteins has been
associated with a variety of processes, such as RNA processing, trafficking and
translation (Bandziulis et al., 1989; Kenan et al., 1991; Kim & Baker, 1993). As the
name implies, GRSF-1 increases the translation efficiency of mRNAs containing a
particular guanine rich sequence. This sequence, AGGGU, is found in the 5’ UTR of
influenza, which is conserved almost intact in all 8 gene segments, and is thought to be
at least partly responsible for selective viral mRNA translation (Kash et al., 2002; Park
et al., 1999a). In addition to the principle AGGGU sequence, there are some deviations
(Table 1), which may still confer increased translation efficiencies (Kash et al., 2002).
The mechanism by which GRSF-1 works to increase translation efficiency is unclear
and although an importance has been established during a viral infection, the precise
cellular purpose of this protein is currently unknown.
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Table 1. Sequences analyzed for GRSF-1 binding. Listed are RNA sequences
evaluated for their ability to bind GRSF-1 in vitro in gel-shift assays. (+) and (-) indicate a
relative comparison for GRSF-1 binding. The shaded portion is the proposed GRSF-1
binding sequence. (Data are from Kash et al. 2002)
Segment

NP
NP-A
NP-B
NP-C
NP-14
NP-12
NP∆3
NP∆6
NP∆9
ns1
u14c
g13/u14c
m1
na
PB1

Sequence

GGAGCAAAAGCAGGGUAGAUAAUCACUCACUGAGUGACAUCAAAAUCAUG
GG------------GUAGAUAAUCACUCACUGAGUGACAUCAAAAUCAUG
GGAGCAAAACCAGG------------UCACUGAGUGACAUCAAAAUCAUG
GGAGCAAAAGCAGGGUAGAUAAU----------GUGACAUCAAAAUCAUG
GGAGCAAAACGAGGGU---------------------------------GGAGCAAAAGCAGG-----------------------------------GG---AAAAGCAGGGUAGAUAAU----------GUGACAUCAAA-----GG------AGCAGGGUAGAUAAU----------GUGACAUCAAA-----GG---------AGGGUAGAUAAU----------GUGACAUCAAA-----GGAGCAAAAGCAGGGUGACAAAGACAUAAUG------------------GGAGCAAAAGCAGGGCGACAAAAGACAUAAUG-----------------GGAGCAAAAGCAGGCCGACAAAGACAUAAUG------------------GGAGCGAAAGCAGGUAGAUAUUGAAAGAUG-------------------GGAGCGAAAGCAGGGGUUUAAAA--------------------------GGAGCGAAAGCAGGCAAACCAUUUGA------------------------

GRSF-1
binding
+++
+
+++
++
+++
++
++
+++
++
++
-

In addition to mRNA processing, protein kinase R (PKR) activation is inhibited
during influenza A virus infection. Upon activation by dsRNA, PKR phosphorylates
eukaryotic initiation factor 2α (eIF2α) thereby shutting down protein synthesis by
interfering with the initiation of translation (Kaufman, 2000). Briefly, following an
initiation event GTP is exchanged for GDP on eIF2 by a guanine nucleotide exchange
factor, eIF2B, in order to recycle the initiation factor for subsequent translation initiation.
However, when eIF2α is phosphorylated by PKR the eIF2/GDP/eIF2B complex is
stabilized in such a way that no GTP exchange is performed and in essence eIF2α is
inactivated. Although NS1 is capable of binding dsRNA (Lu et al., 1995), it remains
unclear how this binding affects the NS1 induced inhibition of PKR activation. Infection
with ts influenza viruses coding for defective NS1 or an influenza virus completely
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without NS1 protein are unable to inhibit the activation of PKR by dsRNA (Bergmann et
al., 2000; Hatada et al., 1999). Further supporting a link between RNA binding ability of
NS1 and repression of PKR activation, the ts mutant viruses mentioned above also
exhibited a reduced ability for binding RNA (Hatada et al., 1999). A peptide fragment
consisting of the first 73 amino acids of NS1 is capable of binding to dsRNA in vitro.
Additionally, as is the case for the full-length protein, the 73 amino acid fragment is able
to dimerize in vitro (Qian et al., 1995). This dimerization is likely necessary for the
protein’s dsRNA binding capabilities since mutagenesis abolishing dimerization also
leads to a loss in dsRNA binding ability (Wang et al., 1999). The three dimensional
structure obtained from X-ray crystalography and nuclear magnetic resonance (NMR)
solution reveal that each 73 amino acid fragment of the dimer is made up of 3 alpha
helices (Chien et al., 1997). Studies have indicated that within each fragment only two
amino acids, Arg-38 and Lys-41, are necessary for dsRNA binding. In these
experiments, it was shown that replacement of Arg-38 with Lys did not affect the
fragment’s ability to bind dsRNA. However, when Arg-38 was replaced with Ala, dsRNA
binding was inhibited and therefore a positively charged amino acid at position 38 is
likely necessary for nucleic acid binding (Wang et al., 1999). Further supporting that the
1-73 amino acid fragment retains all the RNA binding-associated properties of the fulllength protein, pre-incubation of the fragment with dsRNA prior to incubation in
reticulocyte extracts abolishes the ability of the dsRNA to inhibit translation (Qian et al.,
1995). Based on the understood action of dsRNA and the counteraction of NS1 it is
presumed this block in translation inhibition is due to the lack of dsRNA-mediated PKR
activation in the reticulocyte extracts.
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Interestingly, NS1 and the 1-73 amino acid fragment appear to not only bind
dsRNA, but also bind poly(A) RNA as well as a stem-bulge in U6 small nuclear RNA
(snRNA) (Qian et al., 1995). It is presumed NS1 requires highly structured RNA targets
and for this reason, it is capable of binding the previously mentioned RNA molecules.
However, since the secondary structures produced by these RNAs are difficult to predict
with certainty a particular RNA binding structure has not been established for NS1. It
should be noted that NS1 binding does appear to require RNA/RNA duplexes (Chien et
al., 2004). This was established with experiments using DNA/DNA and DNA/RNA
duplexes in gel-shift assays using the 1-73 amino acid fragment as a binding substrate.
In these experiments only dsRNA was capable of binding to the fragment.
It is presumed that NS1 inhibits the PKR activation activity of dsRNA by
sequestering it from the PKR enzyme. However, NS1 has also been found to physically
bind to PKR. In these experiments NS1 was found to co-precipitate with PKR in
influenza infected Hela cell lysates. The interaction was confirmed in a yeast two-hybrid
system (Tan & Katze, 1998). Similar to the dsRNA binding domain, the PKR binding
domain was mapped to the amino terminus of NS1. Additionally, a mutant NS1 protein
incapable of inhibiting the activation of PKR was also unable to bind to the kinase.
However, another group has presented data of their own yeast two-hybrid experiments
and found no indication of NS1 binding to PKR (Falcon et al., 1999). Therefore, the
physical interaction of PKR remains controversial and so would any implication of its
effect on PKR activation.
In addition to the actions of NS1, a cellular PKR inhibitor, P58 inhibitor of protein
kinase (P58IPK), has been shown to be recruited during influenza A virus infections to
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assist in the inactivation of PKR (Lee et al., 1990; Lee et al., 1992). P58IPK is present in
cells as an inactive protein complex which likely consists of both heat shock protein 40
(hsp40) (Melville et al., 1997; Melville et al., 1999) and P52rIPK (Gale et al., 1998).
During influenza A virus infection P58IPK is activated through its dissociation with hsp40
(Melville et al., 1999). Although its anti-P58IPK activity has been established, how
P52rIPK may be affected during influenza A virus infection has yet to be determined.
Other than physical contact, the precise mechanism of PKR inhibition imposed by
P58IPK is not clear at this time. It does appear to involve the ATPase activity of heat
shock protein 70 (Hsp70), a protein factor associated with P58IPK (Melville et al., 1999).
However, due to the fact hsp70 is a chaperone protein, it has been speculated that
P58IPK may somehow act as a co-chaperone in activating an hsp70 mediated re-folding
of the PKR protein, rendering it non-functional. A non-functional PKR leads to a
reduction in phosphorylation of eIF2α, which in turn leads to an increase in protein
synthesis.
Research objectives
Therefore, as there is an apparent role for cap-independent translation in
eukaryotic cells two research objectives were identified: 1. How do levels of capdependent translation compare to cap-independent translation in the host cell during
influenza A virus infection? 2. How are 4E-BP1 and eIF4E, key factors in translation
initiation, affected during influenza A virus infection?
To study the first objective, a dual luciferase assay was used, which measured
the levels of expression of two individual reporter genes in a given sample (summarized
in Fig. 4). In Promega’s Dual-Luciferase Assay Reporter System the firefly (Photinus
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pyralis) and renilla (Renilla reniformis) luciferases are measured in a single lysate by
two consecutive chemical reactions. In order to maintain equal levels of the two
reporter gene transcripts, a bicistronic reporter construct was employed, which
transcribes a single mRNA coding for both the renilla and firefly luciferases. The
translation of the renilla luciferase (Rluc) cistron was initiated by the 5’ cap structure.
The translation of the firefly luciferase (Fluc) was initiated by the inter-cistronic poliovirus
IRES. Therefore, by expressing two different luciferases, a comparison of the
relationship between cap-dependent and cap-independent translation in cells under a
particular treatment was made. Additionally, since the two messages are on a single
mRNA, thereby automatically eliminating any variance in the respective levels of the two
mRNA transcripts, direct measurements of cap-dependent and cap-independent
translation in a single lysate were taken.
As stated previously, the dual luciferase assay uses two consecutive reactions
for the measurement of the two luciferases in a given sample. The firefly and Renilla
luciferases come from distinct evolutionary origins and because of this have distinct
chemical requirements. Specifically, in Promega’s dual luciferase assay the Fluc uses a
Beetle Luciferin substrate whereas the Rluc uses a coelenterazine substrate.
Additionally, neither Rluc nor Fluc require any post-translational modification for activity;
therefore, both luciferases are competent for a luciferase reaction directly following
translation (de Wet et al., 1985; Wood et al., 1984). This eliminates the possibility of
additional post-translation regulation affecting the activity of either of the enzymes,
which lends to a more clearly defined measurement. The Fluc activity is first measured
following addition of the sample lysate to the reaction mixture. A second reagent is then
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added to the mixture, which quenches the first reaction and initiates the second reaction
so the Rluc activity can be measured. The effect of influenza A virus infection on 4EBP1 and eIF4E phosphorylation was measured using phosphorylation-specific
antibodies. By comparing western blots using either the phosphorylation-specific or
total protein antibodies, an evaluation of the phosphorylation state of the proteins was
assessed in influenza A virus infected cells.
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Summary of Dual Luciferase
Protocol

Step 1

Transfect
pcDNA3-rLuc-polIRESfLuc

Step 2
Infect 8 hours post
transfection
Transcription of a
single
bicistronic mRNA
Rluc

Fluc

{5’ cap}
{IRES}

Step 3

Translation

Lyse cells

Rluc

Fluc

cell
Step 4

Measure luciferase activities and
calculate Rluc/Fluc ratio from a
single lysate

Figure 4. A summary of the dual luciferase assay protocol
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Chapter 2: Results
Infection post transfection of the bicistronic reporter construct was determined to
be optimal at 8 hours post transfection
CHO cells were transfected with the bicistronic luciferase reporter plasmid and at
various times post infection cells were harvested beginning at 1 hour post transfection
and taken every hour until 11 hours post transfection. An additional time point at 24
hours post transfection was harvested as a positive control. As figure 5 illustrates very
little luciferase activity was detectable until 6 or seven hours post transfection. At 8
hours post transfection both luciferase activities were detectable. However, when
compared to the levels observed at 24 hours post transfection these activities were
relatively insignificant. Therefore, in order to minimize the amount of luciferase present
in the system prior to infection, 8 hours post transfection was determined to be the
optimal time from which to begin the virus infections.
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Figure 5. Luciferase expression post transfection of pcDNA3-rLucpolIRES-fLuc. CHO cells were transfected with pcDNA3-rLuc-polIRESfLuc or pcDNA3.1+ as a negative control. Cells were harvested at the
indicated time post-transfection and analyzed for luciferase activities.

Transfection of CHO cells using TransFast transfection reagent did not inhibit
infection
To test whether transfection of CHO cells would inhibit virus infection, CHO cells
were either transfected in 24 well plates on glass cover slips with the control vector
plasmid, pcDNA3.1+, or left untreated. Following an 8 hour transfection period the cells
were infected with WSN (MOI=10). At 6 HPI the cells were fixed in 100% methanol at –
20° C for 15 minutes and stained with a FITC conjugated antibody directed against
influenza A virus NP protein. These cells were then visualized with confocalmicroscopy (Fig. 6). No difference in the ratio of positive to negative cells in the
transfected and non-transfected CHO cells was observed. Therefore, it was concluded
that transfection did not affect the infection efficiency of CHO cells.

Transfected cells

Non-transfected cells

Figure 6. Effect of transfection on infection efficiency of CHO cells. CHO
cells were either transfected with pcDNA3.1+ or left untreated. At eight hours post
transfection both sets of cells were inoculated with WSN (MOI=10). At six hours post
infection (HPI) the cells were fixed and stained with a FITC-conjugated antibody directed
against the influenza NP protein. The upper left quadrant of each image is the FITC
image only, the upper right quadrant is the negative evans blue stain and the lower right
quadrant is the overlay of the two images. The antibody was tested for specificity against
influenza NP protein on mock infected cells, which exhibited no reaction with the anti-NP
antibody.
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Influenza A/WSN/33 and influenza A/Memphis/88 infection resulted in an
increased cap-dependent to cap-independent translation ratio
CHO cells were transfected with the bicistronic luciferase reporter plasmid at 8
hours prior to infection with influenza A/WSN/33 (H1N1) virus. Following infection with
either WSN (MOI=10) or a mock inoculum, lysates were harvested at times 4, 6, 8, 10,
12, 14 and 16 hours post infection (HPI). These samples were analyzed using a dual
luciferase reporter assay and the ratio of renilla luciferase (cap-dependent) activity to
firefly luciferase (cap-independent) activity, i.e. Rluc/Fluc, was plotted against time
(Fig.7a). By 16 HPI the ratio of cap-dependent to cap-independent translation in WSN
infected cells had increased to greater than 6 times that of mock infected cells
(P<0.0001). Another influenza A virus, influenza A/Memphis/88, was tested and at 16
HPI the ratio of Rluc/Fluc was 3.8 times that of mock infected cells (data not shown).
An increase in both luciferase activities was observed in WSN infected CHO cells early
in infection, and as illustrated in figure 7b, was particularly dramatic with respect to capdependent translation. By 6 HPI, cap-dependent and cap-independent translation had
respectively increased by factors of 3.8 and 1.6 times that of mock-infected cells
(P<0.0001 for both). In mock infected cells a steady increase over time of capindependent translation was observed. Conversely, in WSN infected cells following the
initial increase, cap-independent translation underwent a steady decrease over time.
The fall off of luciferase activities at times ≥ 12 HPI is attributed to gradual loss of the
monolayer due to cytopathic effect of the virus. To test whether the observed increase
in the absolute values of the luciferase activities was due to an increase in translation or
transcription, semi-quantitative RT-PCR was performed on CHO cells first transfected
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with the bicistronic reporter plasmid and then infected with either WSN (MOI=10) or a
mock inoculum. Since the firefly and renilla luciferases are encoded on a single mRNA,
semi-quantitative RT-PCR analysis of only one of the two luciferases was necessary.
As illustrated in figure 8a, mock-infected cells contained a greater amount of firefly
luciferase message compared to WSN infected cells. β-actin was analyzed in these
samples as a control and as figure 8b illustrates the mock infected cells exhibited higher
levels of β-actin message compared to WSN infected cells. The observed lower levels
of both β-actin and firefly luciferase messages in the virus infected cells can be
attributed to the shut down of host cell mRNA transcription and possible mRNA
degradation due to virus infection. This experiment was repeated and similar results
were observed. Therefore, the observed increase in translation was not due to an
increase in reporter gene transcription.
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Figure 7. Cap-dependent to cap-independent translation ratio in WSN infected CHO
cells. CHO cells were transfected with the pcDNA3-rLuc-polIRES-fLuc reporter plasmid and
subsequently infected 8 hours later with either influenza A/WSN/33 (MOI=10) () or a mock
inoculum (z). Lysates of these cells were harvested at various times post infection and
analyzed for luciferase activities as described in the methods section. (a) Mean ratios of
renilla to firefly luciferase (Rluc/Fluc), i.e. cap-dependent to cap-independent translation. (b)
Means of the individual luciferase activities. Standard deviations are indicated with error bars.
This experiment was repeated and the results were similar.
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Figure 8. Semi-quantification of reporter mRNA in WSN infected CHO cells. For
relative quantification of reporter mRNA, CHO cells were transfected with pcDNA3-rLucpolIRES-fLuc and infected as previously stated. At four hours post infection total RNA was
isolated and semi-quantitative RT-PCR analysis was performed using firefly luciferase (a)
and β-actin specific primers (b). In figure 8b overexposure of the gel was necessary to
visualize the β-actin bands, shown beneath the original image. The cDNA dilution used for
PCR is indicated. This experiment was repeated and the results were similar.
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WSN infection resulted in a shut down of host cell protein synthesis
Since WSN infection of CHO cells resulted in an increase in the translation of the
reporter genes, an 35S-pulse labeling experiment was performed on CHO cells that were
either mock-infected or infected with WSN (MOI=10). Before harvesting at the
respective time points (0, 2, 4 and 6 HPI), the CHO cells were starved for methionine
(M) and cysteine (C) in M and C free media for 15 minutes. Following starvation these
cells were treated with 100µCi of 35S-methionine/cysteine and labeled for 30 minutes.
Following the labeling period the cells were harvested in SDS-PAGE loading buffer.
Once all the time points had been collected, the samples were subjected to SDS-PAGE.
The gel was dried onto filter paper and exposed to X-ray film overnight. As figure 9
illustrates, a dramatic reduction in cellular protein synthesis was observed in WSN
infected CHO cells compared to their respective mock controls.

43

0HPI
M

WSN

2HPI
M

WSN

4HPI
M

WSN

6HPI
M

WSN

Figure 9. Shut-down of host protein synthesis in WSN infected CHO cells.
CHO cells were infected with either WSN (MOI=10) or a mock inoculum and 35S
pulse labeled prior to harvesting at the indicated time post infection. The lysates
were then subjected to SDS-PAGE and autoradiography.
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Expression of the Memphis/88 NS1 resulted in an increased ratio of capdependent to cap-independent translation
Since influenza NS1 has been implicated as an activator of translation (Salvatore
et al., 2002), it was tested whether CHO cells transfected with both the bicistronic
reporter plasmid and an NS1 expression plasmid would exhibit an increase in the capdependent to cap-independent translation ratio when compared to control vector
transfected cells. As shown in figure 10a, the Rluc/Fluc ratio increased 1.3 times in
cells transfected with the NS1 expression plasmid when compared to the control
plasmid (P<0.0001). As illustrated in figure 10b, an increase in both renilla and firefly
luciferase activities, 3.3 and 2.6 times respectively, was observed in NS1 transfected
cells compared to controls (P=0.001 and 0.0019 respectively). Thus, similarly to WSN
infection, a greater increase in cap-dependent translation was observed compared to
the cap-independent form. The increase in reporter activity following transfection of the
NS1 expression plasmid was consistent with other researchers’ results. Salvatore et al.
have determined NS1 to be a translational activator based on reporter gene activities in
NS1 expressing cells (Salvatore et al., 2002). The observations of the present study
suggest the translation activation induced by NS1 is predominantly cap-dependent. To
test whether the increase in the absolute values of the luciferase activities was due to
an increase in translation rather than transcription, semi-quantitative RT-PCR was
performed on CHO cells transfected with both the bicistronic reporter plasmid as well as
with either the NS1 expression plasmid or a control vector. As illustrated in figure 11a,
CHO cells expressing NS1 exhibited lower expression of firefly luciferase message
compared to vector transfected cells. β-actin was also analyzed in these samples as a
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control (Fig. 11b). The lower level of firefly luciferase message can be attributed to the
NS1 imposed inhibition of post-transcriptional processing of cellular pre-mRNAs (Krug
et al., 2003). This experiment was repeated and similar results were observed.
Therefore, the observed increase in translation was not due to an increase in reporter
gene transcription.
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Figure 10. Cap-dependent to cap-independent translation ratio in NS1 expressing CHO
cells. CHO cells were transfected with the pcDNA3-rLuc-polIRES-fLuc reporter plasmid
together with an NS1 expression plasmid or a control vector plasmid. At twenty four hours
post transfection the cells were lysed and analyzed for luciferase activities as described in the
methods section. (a) Mean ratios of renilla to firefly luciferase (Rluc/Fluc), i.e. cap-dependent
to cap-independent translation. (b) Means of the individual luciferase activities. Standard
deviations are indicated with error bars. This experiment was repeated and the results were
similar.
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Figure 11. Semi-quantification of reporter mRNA in NS1 expressing CHO
cells. For relative quantification of reporter mRNA, CHO cells were transfected with
pcDNA3-rLuc-polIRES-fLuc and either an NS1 expression plasmid or a control
vector plasmid. At twenty four hours post transfection total RNA was isolated and
semi-quantitative RT-PCR analysis was performed using firefly luciferase (a) and βactin specific primers (b). The cDNA dilution used for PCR is indicated. This
experiment was repeated and the results were similar.
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Infection with influenza A virus devoid of NS1 expression (delNS1) induced less
of an increase in the ratio of cap-dependent to cap-independent translation
compared to a wild-type virus
Based on the results from the previous NS1 expression experiment, it was
hypothesized that an influenza virus devoid of NS1 expression would not induce an
increase in the ratio of cap-dependent to cap-independent translation. An NS1 deleted
mutant virus, delNS1, developed by Garcia-Sastre and co-workers was used to test this
hypothesis. This group has established that an NS1 deleted influenza virus can
replicate efficiently in type I interferon deficient systems such as Vero cells (Diaz et al.,
1988; Garcia-Sastre et al., 1998). Therefore, Vero cells were first transfected with the
bicistronic reporter plasmid and subsequently infected 8 hours later with delNS1
influenza virus (MOI=10). As shown in figure 12a, delNS1 infection of Vero cells
produced less of an increase in the cap-dependent to cap-independent translation ratio
compared to WSN infection. Although the delNS1 virus induced a statistically
significant ratio increase in Vero cells (P<0.0001), it was only ~70% that of the WSN
induction (Fig. 12a). The ratio increase was due to a relative decrease in capindependent translation (P=0.0157). Additionally, the observed increase in luciferase
activity following WSN infection of CHO cells was not observed following WSN infection
of Vero cells (Fig 12b).
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Figure 12. Cap-dependent to cap-independent translation ratio in delNS1 infected Vero
cells. Vero cells were transfected with the pcDNA3-rLuc-polIRES-fLuc reporter plasmid and
subsequently infected 8 hours later with either delNS1 influenza virus (MOI=10) ( ) or a mock
inoculum (z). Also, as controls, pcDNA3-rLuc-polIRES-fLuc transfected Vero cells were
infected with either influenza A/WSN/33 (MOI=10) () or a mock inoculum (U) and lysed 16
hours post infection. Lysates of these cells were analyzed for luciferase activities as described
in the methods section. (a) Mean ratios of renilla to firefly luciferase (Rluc/Fluc), i.e. capdependent to cap-independent translation. (b) Means of the individual luciferase activities in the
WSN infected Vero cells. Standard deviations are indicated with error bars. This experiment
was repeated and the results were similar.
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Expression of NS1 coupled with infection of delNS1 resulted in a wild-type
increase in the ratio of cap-dependent to cap-independent translation
To confirm that NS1 was necessary to produce a more wild-type increase in the
cap-dependent to cap-independent translation ratio, Vero cells were transfected with the
bicistronic reporter plasmid as well as with either the NS1 expression plasmid or an
empty control vector plasmid. These cells were then infected with delNS1 (MOI=10) or
a mock inoculum, lysed at 16 HPI and analyzed for luciferase activities. DelNS1
infection coupled with NS1 expression rescued a more wild-type cap-dependent to capindependent translation ratio increase when compared to the vector transfected/mock
infected control cells (P<0.0001) (Fig. 13a). A slight ratio increase was again observed
in cells expressing NS1 and in cells infected with delNS1 (P=0.0039 and 0.0055
respectively). As illustrated in figure 13b, an increase in both the renilla and firefly
luciferase activities, by factors of 2 and 1.3 respectively, was observed in NS1
transfected/mock infected cells compared to controls (P=0.0001 and 0.0157
respectively). Additionally, expression of NS1 increased cap-dependent translation in
Vero cells infected with delNS1 when compared to the vector transfected/delNS1
infected cells (P=0.0002). The more wild-type increase in the translation ratio rescued
by expression of NS1 in Vero cells infected with delNS1 was specifically due to an
increase in cap-dependent translation.
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Figure 13. Rescue of a more wild-type translation ratio in delNS1 infected Vero cells by
coupled NS1 expression. Vero cells were transfected with the pcDNA3-rLuc-polIRES-fLuc
reporter plasmid as well as either an NS1 expression plasmid or a control vector plasmid. Three
wells of each group were infected 8 hours later with delNS1 influenza virus (MOI=10) and 3 with
a mock inoculum. Lysates of these cells were harvested at 16 hours post infection and
analyzed for luciferase activities as described in the methods section. (a) Mean ratios of renilla
to firefly luciferase (Rluc/Fluc), i.e. cap-dependent to cap-independent translation. (b) Means of
the individual luciferase activities. Standard deviations are indicated with error bars. This
experiment was repeated and the results were similar.
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Addition of interferon-α did not increase reporter translation in NS1 expressing
Vero cells
Since Vero cells are deficient in their expression of type I IFN, it was
hypothesized this could be the reason Vero cells do not exhibit the dramatic increase in
luciferase activity upon influenza A virus infection or transfection of an NS1 expression
plasmid. Vero cells were transfected with both the bicistronic reporter plasmid and the
NS1 expression plasmid. Cells were then either treated with INF-α or left untreated. As
figure 14 illustrates, cells treated with INF-α exhibited less reporter gene activity
compared to the untreated controls. Therefore, INF-α treatment of Vero cells did not
rescue a more wild-type, NS1-induced increase in reporter gene translation compared
to controls.

Fluc

Rluc

Figure 14. Reporter activity in interferon-alpha treated Vero cells
expressing NS1. Vero cells were transfected with the pcDNA3-rLuc-polIRESfLuc reporter plasmid as well as the NS1 expression plasmid. Half of these cells
were treated with IFN-α and half without treatment as indicated. At twenty four
hours post transfection the cells were harvested and analyzed for luciferase
activities.
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Influenza infection resulted in reduced phosphorylation of 4E-BP1 in late
infection in CHO cells
Since influenza A virus infected CHO cells exhibited high levels of translation, it
was hypothesized that 4E-BP1 is deactivated during infection in order to enhance
translation. Therefore, CHO cells were infected with WSN (MOI=10) or a mock
inoculum and later harvested at 4, 8, 12 and 16 HPI in SDS-PAGE loading buffer.
These lysates were then subjected to SDS-PAGE, transferred and western blotted
individually with antibodies against 4E-BP1 phosphorylated at either S-65 or T-70.
Following image analysis, these blots were washed and incubated with an antibody
directed against total 4E-BP1 (Fig. 15). Once the blots were reanalyzed a comparison
between phosphorylated and non-phosphorylated 4E-BP1 was performed. In infected
cells, 4E-BP1 remained phosphorylated at both S-65 and T-70 at levels equivalent to
mock infected cells until the later times post infection. At 16 HPI phosphorylation at S65 had been reduced on the order of 30% compared to mock infected cells. However,
no significant difference was noted with respect to T-70. Additionally, at 16 HPI faster
migrating species, indicating dephosphorylation of 4E-BP1, were observed.
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Figure 15. 4E-BP1 phosphorylation in WSN infected CHO cells. CHO cells were infected with
WSN (MOI=10) or a mock inoculum. Cells were lysed at 4, 8, 12 and 16 HPI and subjected to SDSPAGE, transferred and western blotted against (a) Phospho-S-65 4E-BP1 or (b) Phospho-T-70 4EBP1. Both blots were then re-probed with an antibody against total 4E-BP1. A similar experiment,
harvesting cells at 8 and 16 HPI was repeated 2 additional times and the results were similar.
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Influenza infection did not affect the phosphorylation state of 4E-BP1 in MDCK
cells
Since CHO cells were not permissive for influenza A virus infection in our system
it was questioned whether, like CHO cells, MDCK cells would also exhibit high levels of
4E-BP1 phosphorylation. Therefore, MDCK cells were infected with WSN (MOI=10)
and later harvested at 4, 8 HPI in SDS-PAGE loading buffer. These lysates were then
subjected to SDS-PAGE in duplicate wells, transferred and western blotted individually
with antibodies against 4E-BP1 either phosphorylated at S-65 or T-70. Following X-ray
exposure and development, these blots were washed and incubated with an antibody
directed against total 4E-BP1 (Fig. 16). Once the blots were reanalyzed a comparison
between phosphorylated and non-phosphorylated 4E-BP1 was performed. 4E-BP1
remained phosphorylated at both S-65 and T-70 at levels equivalent to mock infected
MDCK cells.
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Figure 16. 4E-BP1 phosphorylation in WSN infected MDCK cells. MDCK cells were infected
with WSN (MOI=10) or a mock inoculum. Cells were lysed at 4 and 8 HPI and subjected to SDSPAGE, transferred and western blotted against (a) Phospho-S-65 4E-BP1 or (b) Phospho-T-70 4EBP1. Both blots were then re-probed with an antibody against total 4E-BP1. This experiment was
repeated and the results were similar.
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Chapter 3: Discussion
WSN infection of CHO cells resulted in an increase in the ratio of cap-dependent
to cap-independent translation compared to mock infected cells (Fig. 7a). In order to
understand why this ratio changed, the absolute luciferase values, in relative light units
(RLU), at each of the time points must be examined (Fig. 7b). Infection with influenza
virus initiated a dramatic increase in both of the reporter genes. Initially it was
postulated this increase could be the result of transcriptional activation due to
interaction of the virus with the CMV promoter on the reporter plasmid. However,
according to the semi-quantitative RT-PCR results, the increase in luciferase activity
was not due to transcriptional activation, but rather to an increase in translation of the
available mRNA (Fig. 8). This is contrary to the well documented influenza induced
shut-down of host encoded protein synthesis, which this study confirmed (Fig. 9).
Therefore, the observed increase in luciferase translation in CHO cells was not likely
due to a block or defect in the influenza induced protein synthesis shut-down
mechanism. It was concluded the bicistronic reporter transcript exhibits increased
translation efficiency during influenza infection. In an effort to explain these results the
5’ UTR coded for by the bicistronic reporter construct was sequenced for the possible
identification GRSF-1 binding sites.
A recently discovered cellular protein, GRSF-1, has been implicated in the
selective translation of influenza mRNAs (Kash et al., 2002; Park et al., 1999b). The 5’
UTR of influenza mRNAs contain a conserved sequence, which is recognized by
GRSF-1. The conserved sequence, AGGGU, as well as some variations noted in table
1 have been found to bind GRSF-1 in vitro in gel shift assays and it is proposed this
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binding somehow increases the translation efficiency of mRNAs (Park et al., 1999b). In
their work on GRSF-1, Park and colleagues have demonstrated that removal of GRSF-1
in HeLa cell extracts through immunodepletion reduces the translation of an mRNA
containing the 5’ conserved sequence of the influenza A virus NP protein mRNA.
Furthermore, by reintroducing the GRSF-1, they are able to rescue wild-type translation
levels. Although sequencing the pcDNA3-rLuc-polIRES-fLuc UTR did not reveal one of
the published GRSF-1 binding sites, a similar sequence was identified. The 5’ UTR
coded for by pcDNA3-rLuc-polIRES-fLuc contains an AGGGA, which could account for
the observed increase in translation of the luciferase reporters during influenza A virus
infection of CHO cells. To assess the ability of this sequence in increasing translation
efficiency, deletion and substitution mutant clones of pcDNA3-rLuc-polIRES-fLuc would
need to be generated. The resulting plasmids would then be tested in a side-by-side
comparison with the parental plasmid for their translation efficiency during influenza A
virus infection.
Interestingly, CHO cells transfected with the NS1 expression plasmid together
with the bicistronic reporter plasmid also exhibited an increase in the translation of the
luciferase genes (Fig. 10b). Additionally, as in the influenza infected CHO cells, the
observed translation increase in NS1 expressing cells favored cap-dependent
translation over cap-independent translation (Fig. 10a). The increase in the translation
of the luciferase reporters observed in the NS1 transfected cells implies NS1 plays a
role in the previous observations of a virus induced translation increase. This
translational increase was again confirmed with semi-quantitative RT-PCR (Fig. 11). In
comparison, however, the amount of β-actin appeared not to have been as severely
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reduced in the NS1 transfected cells compared to those levels observed in the influenza
A virus infected cells. These findings are attributed to the transfection efficiency of the
system. Since an MOI of 10 was used in the infection experiments, it is safe to
presume, which the fluorescence staining experiments later confirmed, that nearly
100% of the cells were infected with influenza A virus. Therefore, since infection with
influenza A virus shuts down transcription and nuclear to cytoplasmic export of cellular
mRNAs, a severe reduction in β-actin mRNA levels was observed. However, in the
NS1 expression experiment, transfection of the plasmid was not as efficient as the
infection, approximately 10%. If only 10% of a population of cells is expressing NS1, it
would be consistent that an analysis of the β-actin mRNA levels in a population would
not detect a drastic decrease in β-actin mRNA.
Interestingly, Vero cells infected with influenza A virus did not exhibit an increase
in the absolute values of the luciferase reporters as was the case in the CHO cells (Fig.
12b, 7b). However, an increase was observe in the absolute values of the luciferase
reporters following transfection of the NS1 expression plasmid in Vero cells (Fig. 13b).
It is unclear why such a discrepancy between these two cell lines would be observed.
However, given their different sources and composition, different translation regulatory
properties may be evident. Vero cells do not express type I IFN due to a deletion of
these genes from the genome. Although it seems contrary given type I IFN’s known
inhibition on translation, it was hypothesized lack of type I IFN could be responsible for
both an absence in increased levels of reporter gene translation during infection and a
lesser increase during NS1 expression. To test this, IFN-α was added to the cell culture
media following transfection of the NS1 expression plasmid, which led to a decrease in
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reporter translation compared to controls (Fig. 14). Therefore, it was concluded the lack
of an increase in reporter translation due to influenza A virus in Vero cells was not due
to their inability to induce an IFN-α response. Nevertheless, influenza A virus infection
of Vero cells did result in an increase in the ratio of cap-dependent to cap-independent
translation compared to mock infected cells (Fig. 12a).
Although upon initial examination, it appeared that CHO and Vero cells behaved
differently during influenza infection, a closer analysis revealed the translation ratio
increases observed in both cell lines followed similar patterns. CHO cells infected with
influenza A virus initially exhibited an increase in both the cap-dependent and capindependent reporter. However, following this initial increase a small, but steady
decrease over time in the cap-independent reporter, Fluc, was observed. This is in
contrast to the cap-dependent reporter, Rluc, which continued to increase until a steady
state level was reached (Fig. 7b). Cap-independent translation was diminished when
compared to cap-dependent translation, which was increased to a peak level and then
maintained. Upon examination of Vero cells infected with influenza A virus a similar
trend is visible. Although no increase in reporter activity was observed in infected Vero
cells, the activity of the cap-independent reporter decreased, whereas the activity of the
cap-dependent reporter remained as high as the mock infected cells (Fig. 12b). Since
cytopathic effect (CPE) resulting from virus infection was not controlled for, it is possible
the lack of increased luciferase activity in Vero cells was due to virus infection-induced
loss of the monolayer. Nevertheless, compared to mock controls it was specifically the
inhibition of cap-independent translation that was fully responsible for the observed
increase in the ratio of cap-dependent to cap-independent translation during influenza A
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virus infection of Vero cells. Since an increase in cap-dependent translation was also
observed, the negative regulation of cap-independent translation is only partly
responsible for the increase in the ratio of cap-dependent to cap-independent
translation in influenza A virus infected CHO cells.
Since there is an apparent role for NS1 in increasing the ratio of cap-dependent
to cap-independent translation during influenza A virus infection, it was hypothesized
that infection with delNS1, a virus devoid of NS1 expression, would not result in an
increase in the ratio of cap-dependent to cap-independent translation. However,
delNS1 infection of Vero cells did result in an increase in the translation ratio, yet this
ratio increase was less than that observed in WSN infected Vero cells (Fig. 12a).
Therefore, although NS1 appears not to be solely responsible for the increase in the
ratio of cap-dependent to cap-independent translation in influenza A virus infected cells,
it may be necessary for a wild-type increase. To confirm this, a rescue experiment was
designed where NS1 expression was coupled with delNS1 infection of Vero cells. If
NS1 expression is required for a wild-type increase in the ratio of cap-dependent to capindependent translation in influenza A virus infected cells, coupling NS1 expression with
delNS1 virus infection should result in a more wild-type translational response. This
proved to be the case as NS1 expression coupled with delNS1 virus infection resulted in
a more wild-type translation ratio increase (Fig. 13a). Consistent with the previous
results in NS1 expressing cells, the rescued translation ratio increase was specifically
due to an increase in cap-dependent translation (Fig. 13b). These data further solidify
that NS1 expression plays a crucial role in the influenza A virus induced increase in the
ratio of cap-dependent to cap-independent translation.
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Although it is possible the relatively small translation ratio increase observe in
NS1 expressing cells was due to low transfection efficiency, there is an alternative
explanation, which may also explain why infection with delNS1 virus coupled with NS1
expression resulted in a more wild-type translation ratio. The NS1 protein is found in
the nucleus and cytoplasm of infected cells (Greenspan et al., 1988). NS1 nuclear
localization is presumably due to two separate nuclear localization signals (NLS), which
aid in the translocation of NS1 from the cytoplasm to the nucleus during infection
(Greenspan et al., 1988). NLS usually consist of short stretches of positively charged
amino acids. In contrast, nuclear export signals (NES) often consist of short leucinerich sequences. NS1 contains one such NES in the first 13 amino acids of the amino
terminal portion of the effecter domain (amino acids 134-147) (Greenspan et al., 1988).
Since influenza A virus NS1 is found in both the cytoplasm and nucleus of infected cells,
there must be a regulation strategy in place for trafficking NS1 in-and-out of the nucleus.
Li and colleagues show that expression of an NS1 fragment containing one of the NLS
(amino acids 1-134) results in total nuclear localization. Conversely, expression of an
NS1 fragment containing one of the NLS and the NES (amino acids 1-147) results in
complete cytoplasmic localization. However, the adjacent 14 amino acids (amino acids
148-161) appear to serve as an inhibitor for the NES as an NS1 fragment consisting of
amino acids 1-161 is localized in both the nucleus and the cytoplasm of transfected
cells. Addition of the second NLS leads to the complete nuclear retention of the protein
fragment, which is also the case for the full-length protein (Li et al., 1998). Therefore,
the 14 amino acid sequence (amino acids 148-161) of influenza A virus NS1 may serve
as an inhibitor for cytoplasmic localization. The authors hypothesize that since
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influenza infection results in NS1 cytoplasmic and nuclear localization, there is a viral
protein(s) that is responsible for “unmasking” the NES from the 14 amino acid inhibitor
(Li et al., 1998). However, as yet no influenza A virus protein has been implicated in
performing this unmasking. A similar scenario has been described in adenovirus
infected cells. The NES of the adenovirus E4 34-kDa protein is active only when the
protein is bound to the E1B 55-kDa viral protein (Dobbelstein et al., 1997). Regulation
of NS1 localization may explain the discrepancy in the cap-dependent to capindependent translation ratio between cells expressing NS1 and cells both expressing
NS1 and infected with delNS1 influenza virus. Although not tested, cells expressing
NS1 alone may have the majority of NS1 localized in the nucleus, which could diminish
any effect NS1 may have on translation. However, infection of delNS1 influenza
coupled with NS1 expression may provide the necessary protein(s) for unmasking the
NES of NS1, which could result in more cytoplasmic NS1 localization and therefore a
greater effect on the ratio of cap-dependent to cap-independent translation. The
localization of NS1 in NS1 expressing/delNS1 virus infected cells has not been
established and therefore it is currently not known whether the localization of NS1 may
contribute to the rescue of a wild-type translation ratio in these cells compared to cells
expressing NS1 alone.
The rescue experiment in Vero cells illustrates the two components of the
influenza A virus infection-induced increase in the ratio of cap-dependent to capindependent translation. It is possible for the translation ratio increase to be due to an
increase in cap-dependent translation. On the other hand, it is also possible for the
translation ratio increase to be due to a decrease in cap-independent translation. For
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the case of influenza A virus infection, it appears both components are needed for a
wild-type increase in the ratio of cap-dependent to cap-independent translation. In the
WSN infected Vero cells, there was no change in cap-dependent translation compared
to mock infected cells. What was responsible for the ratio increase during WSN
infection of Vero cells was the inhibition of cap-independent translation (Fig. 12b).
Conversely, delNS1 infection of Vero cells resulted in a decrease in both capindependent and cap-dependent translation compared to mock infected cells (Fig. 13b).
Therefore, because delNS1 was unable to maintain a cap-dependent translation level
equal to that of the mock infection, it induced less of a ratio increase. However,
coupling NS1 expression with delNS1 infection resulted in an increase in capdependent translation and therefore a more wild-type increase in the translation ratio
(Fig. 13b). Since delNS1 influenza virus is capable of reducing cap-independent
translation there must be a viral protein(s) other than NS1, which is capable of inhibiting
cap-independent translation. A possible mechanism for this will be discussed later.
CHO cells were chosen for their propensity for transfection and their ability to be
infected by influenza A virus. Before beginning the infection/transfection experiments
the optimal time for virus infection post transfection of the bicistronic reporter plasmid
was determined. Due to the half lives of Fluc and Rluc, 3 and 5 hours respectively
(Bronstein et al., 1994; Thompson et al., 1991), this was necessary to minimize the level
of luciferase translated pre-infection. In a time course experiment where cells were
harvested at various times post transfection, It was determined that 8 hours post
transfection was optimal since, although both luciferase activities were measurable,
they were relatively insignificant when compared to the activities measured at 24 hours
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post transfection. Also, in the Promega Dual Luciferase Reporter Assay System Fluc
produces approximately 53% more light than Rluc. Therefore, although the light output
of Fluc and Rluc are not molar equivalents, the light output does represent the trend of
cap-dependent and cap-independent translation in the system used. Since the 53%
discrepancy was not adjusted for in these analyses, the amount of Fluc, i.e. capindependent translation, has been overestimated. Furthermore, due to this
overestimation, calculations of the ratio of cap-dependent to cap-independent
translation have been conservative.
Although influenza A virus can infect CHO cells, a block in virus growth in CHO
cells was observed in this study. This was discovered when attempting to grow a stock
of WSN virus in CHO cells. Following infection, no hemagglutination (HA) titer at 1, 2 or
3 days post infection was observed. It is unclear why these results were observed
especially in light of the observed production of viral proteins in the 35S pulse labeling
experiment (Fig. 9). Additionally, there has been a previous report of WSN virus growth
in CHO cells (Chelbi-Alix et al., 1998). Nevertheless, since a normal shut-down of host
encoded protein synthesis was observed in CHO cells upon infection with virus grown in
MDCK cells, it was concluded CHO cells would be an adequate model for studying
influenza A virus translational control (Fig. 9). There is a range of possibilities for
explaining the lack of virus growth in CHO cells. Perhaps the particular WSN strain
used in these experiments is simply not well adapted for growth in CHO cells and
although amplification is not possible, overwhelming the cells with a high MOI resulted
in infection.
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Some have suggested that transfecting cells with plasmid DNA results in a
reduction in the efficiency of infection. However, the data presented here do not
support this suspicion as is evident in the comparison of fluorescently stained
transfected and non-transfected, influenza A virus infected CHO cells (Fig. 6).
However, that is not to say that in all situations transfection has no effect on virus
infection. A precise mechanism for reduced infection efficiency due to transfection
would be difficult to analyze since a wide variety of transfection reagents and
techniques are used throughout the scientific community. However, for the case of lipid
transfection reagents, such as the TransFast Reagent (Promega) used in this work, it
has been suggested the interferon system may be activated. If an interferon response
is elicited prior to infection, it is plausible that cells would have ample time to activate
the production of anti-viral molecules and in general, bringing the cell into an anti-viral
state. Of the anti-viral proteins induced from a type I IFN response, there are three
most highly understood: PKR, 2’,5’-Oligoadenylate Synthetase (OAS)/RNAse L and the
Mx proteins (Basler & Garcia-Sastre, 2002). Although a basal level of PKR is
expressed in cells for the purpose of acute activation from dsRNA, PKR gene
expression is increased upon activation of type I IFN (Nakaya et al., 2001). An increase
in PKR expression in conjunction with the appropriate activating substrate, including but
possibly not limited to dsRNA, could lead to the phosphorylation of eIF2α and therefore
an inhibition of translation. OAS/RNAse L leads to a degradation of cellular as well as
viral mRNA (Justesen et al., 2000). Upon activation by type I IFN, OAS converts ATP
into 2’,5’-oligoadenylates which in turn activate the degradation activity of RNAse L
(Nakaya et al., 2001). Finally, induction of the Mx proteins has been shown to interfere
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with viral RNA synthesis and vRNP transport (Krug et al., 1985; Weber et al., 2000).
Taken together, lipid transfection reagent-dependent induction of any of the mentioned
type I IFN effecter molecules could result in the inhibition of viral infection.
According to experiments using the phosphorylation-specific antibodies, 4E-BP1
phosphorylation remained high during influenza A virus infection (Fig. 15 and 16). A
reduction in the phosphorylation of 4E-BP1 was not observed until late in infection of
CHO cells (Fig. 15). Additionally, it appeared that 4E-BP1 was highly phosphorylated in
MDCK cells during influenza A virus infection (Fig. 16). Bolstering the phosphorylationspecific antibody data was the observation of faster migrating species of 4E-BP1
present in the influenza A virus infected CHO cells late in infection. Faster migration on
SDS-PAGE of 4E-BP1 is indicative of a reduced phosphorylation state of the protein.
Finally, in agreement with the theory as to the phosphorylation hierarchy of 4E-BP1, the
band directly below the slowest (most highly phosphorylated) band is only visible when
using the phospho-T-70 antibody and not the phospho-S-65 antibody. This would
indicate that S-65 is either the last site phosphorylated or the first to be
dephosphorylated.
Since many stresses, including viral infection, have been found to result in a
dephosphorylation of the 4E-BPs (Gingras et al., 1996; Svitkin et al., 1998),
observations of high phosphorylation levels are somewhat surprising. However, since
influenza A virus appears to be adept at combating the cellular defenses, regulation
favoring 4E-BP1 deactivation is not unreasonable. Highly phosphorylated 4E-BP1
would be beneficial for influenza virus replication since influenza A virus mRNAs are
translated in a cap-dependent manner. Additionally, observations of a highly
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phosphorylated 4E-BP1 are consistent with the high cap-dependent translation found 810 HPI in CHO cells. 4E-BP1 dephosphorylation has been associated with apoptosis
and since influenza A virus induces apoptosis in cells (Horton et al., 2002; Lin et al.,
2002; Takizawa et al., 1993; Tee & Proud, 2000), this is likely the reason why 4E-BP1 is
dephosphorylated later in infection. Additionally, it remains to be investigated whether
influenza virus infection is involved in up-regulating the phosphorylation of 4E-BP1.
Since virus infection can be considered a cellular stress, it is possible the host cell’s
defense system would lead to the dephosphorylation of 4E-BP1 in an attempt to shut
down translation, much like it leads to the phosphorylation of eIF2α. In fact there is a
report, which hints at the possibility of PKR activation leading to the dephosphorylation
of 4E-BP1 (Jeffrey et al., 2002). PKR regulation leading to dephosphorylation of 4EBP1 would be logical since both 4E-BP1 dephosphorylation and eIF2α phosphorylation
have similar inhibitory effects on translation. As stated previously, eIF2α is
phosphorylated by PKR upon activation by double stranded RNA. The effects, if any,
dsRNA has on 4E-BP1 phosphorylation has not been determined. However, if dsRNA
did lead to a dephosphorylation of 4E-BP1 through a PKR-dependent pathway, this
would likely be inhibited by NS1 through the NS1-sequestering of dsRNA. Alternatively,
the induction of the PKR inhibitor, P58IPK, would also likely inhibit any PKR induced
dephosphorylation of 4E-BP1.
It has been shown that eIF4E is dephosphorylated in influenza infected cells
(Feigenblum & Schneider, 1993). Moreover, eIF4E phosphorylation has been
implicated in regulating the ratio of cap-dependent to cap-independent translation, albeit
with conflicting results. eIF4E phosphorylation by over-expressed MNK1 has been
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linked to the down-regulation of cap-dependent translation, and furthermore, expression
of a non-phosphorylatable mutant eIF4E results in “partial reversal of this effect,” i.e.
with non-phosphorylatable eIF4E, MNK1 activity has little effect on cap-dependent
translation (Knauf et al., 2001). However, another group has recently presented data to
the contrary, that dephosphorylation of eIF4E results in an increase in cap-independent
translation (Dyer et al., 2003). eIF4E phosphorylation was a logical characteristic to
analyze during influenza A virus infection. Unfortunately, detection of any consistent
level of eIF4E phosphorylation in either mock or influenza infected CHO cells was not
possible under serum free conditions. The validity of the phosphorylation-specific eIF4E
antibody was assessed by treating CHO cells with 20% FBS for 2 hours prior to
harvesting. There are two possibilities which would account for these negative results:
1) eIF4E is not phosphorylated in this system due to the use of a serum free cell culture
medium throughout the experiments. 2) The level of eIF4E phosphorylation is simply
below levels detectable with the phosphorylation-specific antibody. In either case, these
results are inadequate to define how eIF4E phosphorylation is affected in influenza A
virus infected CHO cells. Likewise, what effect this phosphorylation has on the ratio of
cap-dependent to cap-independent translation during influenza A virus infection remains
unknown.
Influenza A virus infection results in the preferential translation of influenza viral
mRNAs, which are very similar in structure to the host cell mRNAs. Even though
influenza A viral mRNAs are capped at their 5’ end and polyadenylated at their 3’ end,
much like cellular mRNAs, there is a dramatic reduction in the amount of cellular protein
synthesis compared to the high translation efficiency of viral mRNAs. Since influenza A
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virus mRNAs require the same machinery that cellular capped mRNAs require, the
method for selectively translating viral messages is not an obvious one. Poliovirus
infection results in the cleavage of eIF4G (Etchison et al., 1982; Lee et al., 1985), a key
protein in cap-dependent translation. Since poliovirus mRNA is translated capindependently via an IRES, regulation shutting down cap-dependent translation makes
good sense. Since influenza A virus requires cap-dependent translation for its own life
cycle a different strategy must be employed for translating influenza proteins first and
foremost over those of the host cell.
Due to its imposed inhibition of host cell pre-mRNA processing (Chen & Krug,
2000; Chen et al., 1999; Li et al., 2001b; Nemeroff et al., 1998), the influenza A virus
NS1 protein was thought to be responsible for the dramatic shut down in host cell
translation. However, this theory is likely not true for a variety of reasons. In addition to
inhibiting cellular pre-mRNA processing, NS1 has also been shown to increase the
translation efficiencies of influenza mRNAs (Aragon et al., 2000; de la Luna et al., 1995;
Enami et al., 1994; Enami & Enami, 2000). Additionally, this report as well as others,
have observed increased translation of reporter genes due to NS1 expression
(Salvatore et al., 2002). Although a mechanism has not been proposed for these
observations, it is possible that NS1 up-regulates the activity of a host cell translational
enhancer. GRSF-1 would serve as a possible candidate since the sequence coding for
the UTR of the bicistronic reporter used in these experiments contains a sequence
similar to those published as the putative GRSF-1 binding sequence (Table 1) (Kash et
al., 2002). If the UTR of the reporter used in these experiments does contain a binding
site, this would indicate an association between GRSF-1 activity and NS1 expression.
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Although NS1 may localize to the nucleus of the host cell, it is not likely that NS1 acts
as a transcription factor for increasing expression of GRSF-1 mRNA. Even if GRSF-1
mRNA expression was up-regulated, the NS1 inhibition of cellular pre-mRNA
processing would keep those mRNAs from maturing. Therefore, any effect NS1 may
have on GRSF-1 would likely involve an increase in the activity of the available GRSF1. NS1 might accomplish this through physical interaction with GRSF-1 or through
interaction with GRSF-1 regulators. Since NS1 has been found physically associated
with several cellular proteins including both nuclear (CPSF and PABII) and cytoplasmic
(eIF4G and PABI) proteins (Aragon et al., 2000; Burgui et al., 2003; Chen & Krug, 2000;
Chen et al., 1999; Li et al., 2001b; Nemeroff et al., 1998), such interaction is plausible.
An NS1 induced activation of GRSF-1 would explain the observed increase in reporter
gene translation in NS1 expressing cells. It would also imply a possible mechanism for
the NS1 increase in translation of influenza mRNAs, which contain GRSF-1 binding
sites (Kash et al., 2002).
Another model proposed to explain the influenza A viral shut-down of host
protein synthesis involves the inhibitory effect of NS1 on cellular pre-mRNA processing
(Chen & Krug, 2000; Chen et al., 1999; Li et al., 2001b; Nemeroff et al., 1998).
Although one would expect to observe a decrease in protein production from a
reduction in mRNA expression, this theory does not take into account the fully
processed and mature cellular mRNAs in the cytoplasm of the cell upon infection.
These mRNAs are still competent for translation and since cellular mRNA degradation
does not occur until later in infection (Zurcher et al., 2000), after the observed shutdown of host encoded protein synthesis, inhibition of pre-mRNA processing is not likely
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responsible. Additionally, since delNS1 influenza virus, which does not express NS1,
can induce a shut-down in host protein synthesis (Salvatore et al., 2002), neither an
NS1 activation of GRSF-1 nor its inhibition of pre-mRNA processing can account for the
protein synthesis shut-down. Therefore, there is another factor, or set of factors,
induced by influenza A virus infection, which shuts down host protein synthesis.
The requirement for cap-dependent translation in influenza A virus infected cells
is self evident due to the cap-dependent translation of influenza mRNAs. During virus
infections cells often attempt to shut-down cap-dependent translation, for which PKR is
largely responsible. However, since the actions of NS1 and the recruitment of P58IPK
inhibit PKR activation in influenza A virus infected cells this shut-down is thwarted.
There have been previous observations of eIF2α dependent increases in IRES driven
translation. In two of these studies, cells were stressed with either genotoxins or amino
acid starvation (Fernandez et al., 2002; Subkhankulova et al., 2001). In these studies
the activities of reporters translated via the c-myc, and cat-1 IRES, respectively, were
analyzed. In the remaining study, cell differentiation leading to eIF2α phosphorylation
was found to cause an increase in translation driven via the vascular endothelial growth
factor (VEGF), c-myc and EMCV IRES (Gerlitz et al., 2002). Although there has been
an observation of eIF2α phosphorylation during poliovirus infection, a direct comparison
of the effects of phosphorylated and nonphosphorylated eIF2α on the efficiency of
poliovirus IRES translation has not been conducted (O'Neill & Racaniello, 1989). The
authors suggest that in addition to eIF4G cleavage, eIF2α phosphorylation may aid in
shutting down host cell cap-dependent translation (O'Neill & Racaniello, 1989). It is
therefore possible that the poliovirus IRES can continue to initiate translation even
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under conditions of high eIF2α phosphorylation. However, if this theory is taken further
to hypothesize that eIF2α phosphorylation enhances poliovirus IRES driven translation;
a reasonable mechanism for explaining the observation of decreased cap-independent
translation during influenza virus infection may be proposed. During influenza A virus
infection PKR is inactivated, inhibiting the phosphorylation of eIF2α (Katze et al., 1988).
Therefore, the lack of eIF2α phosphorylation may explain the observed reduction in
cap-independent translation compared to mock infected cells. To test this theory, one
might express a constitutively active PKR in influenza A virus infected cells. If the lack
of eIF2α phosphorylation is responsible for the reduced cap-independent translation in
infected cells, the resulting hyperphosphorylation of eIF2α should increase capindependent translation. Increased phosphorylation of eIF2α is not consistent with
increased levels of any translation using the traditional eIF2-GTP-mettRNA as the vehicle
for introducing the initiating amino acid for protein synthesis. Therefore, a nontraditional
use of eIF2 or a novel protein factor would likely be necessary for initiating protein
synthesis from IRES sequences during stress or cell differentiation as described above.
As a whole, these data provide evidence that influenza A virus infection not only
inhibits the translation of host cell mRNA, but may also enhance the translation of
particular mRNA subsets. These mRNA subsets may include those containing GRSF-1
binding sites in the 5’ UTR. However, the involvement of other translational upregulators cannot be ruled out. Although the observations of high translation levels
during infection and NS1 expression may be anomalous due to the UTR of the reporter
transcript, they are consistent with previous reports. There is a possible translationenhancing sequence in the UTR of pcDNA3-rLuc-polIRES-fLuc transcript that may bind
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GRSF-1 or another related protein. Being a host cell protein, GRSF-1 likely provides
enhanced translation of host cell mRNAs as well. Identifying these mRNAs would be
interesting in establishing a function for GRSF-1. Additionally, expression of the mRNA
subset for which translation is enhanced during influenza A virus infection apparently
does not inhibit virus replication. If such were the case then viral evolution would have
likely selected for a different translation strategy. Therefore, it would be interesting to
identify how the proteins originating from this subset of mRNA affect influenza A virus
infection, if at all.
These data also indicate that in comparison to cap-dependent translation, capindependent translation is partially inhibited during influenza A virus infection. Since it
has been established that cap-independent translation is variably affected by cellular
stresses, this indicates a possible role for cap-independent translation in combating
influenza A virus infection. Perhaps there are mRNAs translated cap-independently
coding for anti-influenza genes and somehow the translation of these mRNAs is meant
to be up regulated during infection.
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Chapter 4: Materials and Methods
Cells and viruses
All cell culture media contained antibiotics throughout all procedures (Cambrex
Corporation). Chinese Hamster Ovary (CHO) cells were grown and maintained in HyQCCM5 serum free media (HyClone Laboratories, Inc.). Vero cells were grown and
maintained in VP-SFM serum free media (Invitrogen Corporation). Madin Darby Canine
Kidney (MDCK) cells were grown and maintained in EMEM with 10% FBS (HyClone
Laboratories, Inc.). All counting of cells was performed on a hemicytometer. Influenza
A/Memphis/88 (H3N2) was a kind gift from Robert Webster (St. Jude Children’s
Research Hospital, Memphis, TN). delNS1 influenza was a kind gift from Adolfo GarciaSastre (Mount Sinai School of Medicine, NY, NY). Influenza A/WSN/33 (H1N1) and
influenza A/Memphis/88 viruses were grown and titrated by TCID50 assay (see
description below) in MDCK cells in OptiMEM (Invitrogen Corporation) plus TPCKtreated trypsin (1µg/ml) (Sigma-Aldrich, Inc.). delNS1 influenza virus was grown and
titrated by TCID50 assay in Vero cells in VP-SFM plus TPCK-treated trypsin (1µg/mL).
Virus stock growth
For influenzas A/WSN/33 and A/Memphis/88 MDCK cells were grown to near
confluency in 75cm2 flasks in their normal growth medium. On the day of infection a
1:1000 dilution of the respective stock virus was made in OptiMEM. The cell monolayer
was washed 2 times in PBS and incubated in a 500µL volume of the virus dilution. After
a 1 hour adsorption period at 37°C, the monolayer was washed 1 time with PBS and 12
mL of OptiMEM plus TPCK-treated trypsin (1µg/mL) was added to the flask. The cells
were then incubated at 37°C for approximately 2 days before the supernatant was
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collected and clarified by centrifugation. The virus containing supernatant was then
aliquoted and stored at –70°C. For delNS1 influenza virus Vero cells were grown in VPSFM to near confluency in a 75cm2 flask. On the day of infection a 1:1000 dilution of
the stock virus was made in VP-SFM. The cell monolayer was washed 2 times in PBS
and incubated in a 500µL volume of the virus dilution. After a 1 hour adsorption period
at 37°C the monolayer was washed 1 time in PBS and 12 mL of VP-SFM plus TPCKtreated trypsin (1µg/mL) was added to the flask. The cells were then incubated at 37°C
for approximately 2 days before the supernatant was collected and clarified by
centrifugation. The virus containing supernatant was then aliquoted and stored at –
70°C.
Hemagglutination (HA) titering
For each sample to be titered, 2 fold serial dilutions of the sample were made in
a 50µl volume of PBS. 50µl of undiluted PBS was used as a negative control. 50µl of
.5% processed chicken red blood cells (see recipes) was mixed with each of the
dilutions and incubated at room temperature for 30 minutes. The plates were then
examined for hemagglutination. Negatives were scored as having a red button of
chicken red blood cells that ran when the plate was tilted. Positives were scored as
having no button or a button, which did not run when the plate was tilted.
TCID50 assay of virus titer
MDCK and Vero cells were grown to confluency in a 25cm2 flask with growth
media. The day prior to setting up the TCID50 these cells were trypsinized and
resuspended in 10 mL of growth media and plated on a 96 well tissue culture plate at
100µL/well. On the day of titration the virus to be titrated was diluted in 10 fold serial
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dilutions in OptiMEM when titrating in MDCK and in VP-SFM when titrating in Vero cells.
The 96 well plate of cells was washed 2 times in PBS and 8 replicate wells representing
the dilutions spanning 10-1-1011 were inoculated using a 50 µL inoculum volume. In
addition 8 wells were mock infected with OptiMEM. Following a 1 hour adsorption
incubation at 37° the inoculum was removed from the wells followed by washing with
100µL of PBS/well. OptiMEM or VP-SFM plus TPCK-treated trypsin (1µg/mL) was
added at a volume of 100µL/well. The plate was allowed to incubate for 3 days at 37°C
before staining. Briefly, the supernatant was removed from the plate and the
formalin/crystal violet stain was added and incubated for 10-15 minutes at room
temperature. The stain was removed and the plate was washed in gently running
water. Once the plate had dried a TCID50 titer was calculated using the Reedy/Munch
calculation method.
Plasmids
The bicistronic reporter plasmid, pcDNA3-rLuc-polIRES-fLuc, was a kind gift from
Nahum Sonenberg (McGill University, Montreal, Quebec, Canada). The NS1
expression plasmid, pcDNA3.1+NS1, was made by cutting the NS1 open reading frame
derived from influenza A/Memphis/88 out of a pATX vector (obtained from Robert
Webster, St. Jude Children's Research Hospital, Memphis, TN) and cloning it into the
pcDNA3.1+ vector (Invitrogen Corporation). For expression of only NS1, the resulting
cloned plasmid was then mutagenized using the Quik Change Site-Directed
Mutagenesis method (Stratagene) in two locations thereby inserting two stop codons
near the 5’ end of the NS2 transcript, which are silent in the NS1 transcript. The
forward primer used was as follows:
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5’CCAGGACATACTATAGAGGATGTAAAAAATGCAATTGGGGTCC3’. The reverse
compliment to this was used as the reverse primer (Integrated DNA Technologies, Inc.).
The nucleotides in underlined bold represent the two sites mutated to adenosines.
These two mutations inserted two stop codons, which correspond to the 14th and 17th
amino acid residues of NS2. The pcDNA3.1+NS1 sequence was confirmed by
sequencing on an ABI PRISM automated sequencer (Applied Biosystems Corporation).
All plasmid preparations were done using the Plasmid Midi Kit purification system
(Qiagen, Inc.). DNA concentrations were determined according to absorbance readings
at 260 nanometers on a spectrophotometer (Milton Roy Company). NS1 expression
was confirmed by immunocytochemistry with an anti-NS1 antibody (obtained from
Adolfo Garcia-Sastre, Mount Sinai School of Medicine, NY, NY). The pcDNA3 and
pcDNA3.1+ expression vectors utilize a cytomegalovirus derived promoter.
DNA sequencing
Polymerase chain reaction (PCR) of the desired segment was performed according to
the table of primers below with the indicated annealing temperatures using PWO
polymerase according to the manufacturer’s specifications (Roche). 25µl of the PCR
reaction was run on a 1% agarose gel and the band of interest was cut out and purified
using the Qiaquick gel extraction kit according to the manufacturer’s specifications
(Qiagen). The resulting gel extraction was then split into two sequencing reactions, one
for each primer used in PCR, using BigDye (version I) according to the manufacturer’s
specifications (ABI). The reaction was ethanol precipitated by adding 1/10 the volume
of 3M sodium acetate and 2 times the volume of 100% ethanol. The precipitate was
spun down in a microcentrifuge at maximum speed for 30 minutes. The pellet was
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washed with 75% ethanol and spun in a microcentrifuge at maximum speed for 10
minutes a total of two times. The pellet was dried under a vacuum and resuspended in
20µl of TSR buffer. The sample was then heated to 95°C for 5 minutes followed by a
quick cooling on ice for 5 minutes and loaded on an ABI Prism 310 sequencer
according to the manufacturer.
Dual Luciferase Assays
CHO infection with influenza A/WSN/33 and influenza A/Memphis/88
CHO cells were plated at a concentration of 1X105 cells/well on a 24 well plate
the day prior to transfection. pcDNA3-rLuc-polIRES-fLuc (0.75µg) was transfected per
well at 1:1 ratio with TransFast Transfection Reagent (Promega Corporation) according
to manufacturer’s specifications. Following an 8 hour incubation at 37°C, the
monolayers were washed 2X with PBS and inoculated with either a mock inoculum or
with approximately 10 TCID50 units per cell of influenza A/WSN/33 virus. After 1 hour of
adsorption at 37°C, the virus was removed and the monolayers were washed 1X with
PBS and incubated in fresh medium at 37°C. Except for the time 4 HPI (hours post
infection) where mock and experimental wells were harvested in duplicate, at all other
time points (6, 8, 10, 12, 14 and 16 HPI) mock and experimental wells were harvested
in duplicate and quadruplicate respectively by lysis in 100µl of passive lysis buffer and
frozen at -20°C. These lysates were analyzed by using the Dual-Luciferase Reporter
Assay System (Promega Corporation) on a TD 20/20 luminometer (Turner Designs,
Inc.) according to each manufacturer’s specifications.
Vero cell infection with delNS1 influenza virus
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Vero cells were plated at a concentration of 1X105 cells/well on 24 well plates 2
days prior to transfection. Three µg of pcDNA3-rLuc-polIRES-fLuc was transfected per
well at 1:1 ratio with TransFast Transfection Reagent. More DNA was used in Vero
cells due to less transfection efficiency observed compared to CHO cell transfection.
Following an 8 hour incubation at 37°C, the monolayers were washed with PBS and
inoculated with either a mock inoculum or with approximately 10 TCID50 units per cell of
delNS1 influenza virus. After a 1 hour adsorption at 37°C, the virus was removed, the
monolayers were washed 1X with PBS and incubated at 37°C in fresh medium. For
each time point 4, 8, 12, 13, 14 and 16 HPI, mock and experimental wells were
harvested in duplicate and triplicate respectively and analyzed by using the dual
luciferase assay as previously described.
NS1 transfection experiment
CHO cells were plated at 1X105 cells/well on a 24 well plate the day prior to
transfection. pcDNA3-rLuc-polIRES-fLuc (0.75µg) was transfected at 1:1 ratio with
TransFast Transfection Reagent into each of six wells. Additionally, 3 of these wells
were transfected with 1µg each of pcDNA3.1+ control vector and 3 with 1µg each of
pcDNA3.1+NS1 expression plasmid. At 24 hours post transfection, the cells were
harvested and analyzed by using the dual luciferase assay as previously described.
NS1 rescue experiment
Vero cells were plated at a concentration of 2X105 cells/well the day before
transfection. Twelve wells received 3µg each of pcDNA3-rLuc-polIRES-fLuc, 6 of which
received 4µg each of pcDNA3.1+NS1 whereas the other 6 received 4µg each of
pcDNA3.1+. Eight hours later, three wells of each set were either mock infected or
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delNS1 influenza virus infected (MOI=10) as stated previously. At 16 HPI the cells were
harvested and analyzed by using the dual luciferase assay as previously described.
Vero infection with influenza A/WSN/33
Vero cells were plated at a concentration of 2X105 cells/well the day before
transfection. Six wells were transfected with 3µg each of pcDNA3-rLuc-polIRES-fLuc
and, after an 8 hour incubation at 37°C, 3 wells were infected with influenza A/WSN/33
(MOI=10) and 3 wells were mock infected as previously described. Cells were
harvested at 16 HPI and analyzed by using the dual luciferase assay as previously
described.
Semi-quantitative RT-PCR
CHO infection with influenza A/WSN/33
CHO cells were plated, transfected with pcDNA3-rLuc-PolIRES-fLuc and infected
with influenza A/WSN/33 as described for the dual luciferase assays. At 4 HPI cells
were harvested and total RNA was extracted using the Rneasy Mini Kit according to the
manufacturers specifications (Qiagen). To ensure no DNA contamination occurred an
on-column DNA digestion was performed using the RNase-Free DNase Set (Qiagen).
An equal amount of total RNA (0.8-1 µg) from mock infected and WSN infected CHO
cells was reverse transcribed into cDNA using the GeneAmp RNA PCR kit with an
oligo-d(T)16 primer (Applied Biosystems). Prior to the addition of reverse transcriptase,
the samples were heated to 75°C for 3 minutes then cooled on ice for 5 minutes. The
samples were then reverse transcribed in a one step cycle: 42°C for 45 minutes, 99°C
for 5 minutes, and 5°C for 5 minutes. The resulting cDNAs were serially diluted 2 fold
and 2µl of each dilution from both mock and WSN infected cells was PCR amplified with
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the Expand High Fidelity PCR System (Roche, Inc.) in duplicate reactions using either a
firefly luciferase or a β-actin specific primer set according to the manufacturer’s
specifications:
Primer

Sequence 5’ - 3’

Fluc forward

AAGGCCCGGCGCCATTCTATC

Fluc reverse

ATAATCATAGGACCTCTCACACACAGTTCGC

β-actin forward

GGGTCAGAAGGATTCCTATG

β-actin reverse

GGTCTCAAACATGATCTGGG

An equal volume of the PCR product for each dilution was loaded and run on a 1%
agarose gel containing ethidium bromide. The gel was then visualized using a
FluorChem 8800 Imaging System (Alpha Innotech Corp.).
NS1 transfected CHO cells
CHO cells were transfected with pcDNA3-rLuc-PolIRES-fLuc and either
pcDNA3.1+NS1 or pcDNA3.1+ as described in the dual luciferase assay. Cells were
harvested at 24 hours post transfection and the RNA was analyzed as described for the
WSN infected CHO cells.
eIF4E phosphorylation studies and antibodies
CHO cells were plated at 4X105 cells per well in 6 well plates 1 prior to infection.
On the day of infection, the monolayers were washed 2X with PBS and inoculated with
either WSN (MOI=10) or a mock inoculum. Following a 1 hour adsorption incubation at
37°C, the monolayers were washed 1X with PBS and replaced with fresh media. At 6
and 8 HPI the monolayers were washed 1X with PBS and lysed in 100µl of SDS-PAGE
loading buffer (Bio-Rad Laboratories, Inc.). Twenty µL of each lysate were run on a
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12% SDS-PAGE gel (Invitrogen Corporation) and transferred for 1 hour at a constant
voltage of 100 to a PVDF membrane in a Tris-Glycine transfer buffer (see recipes) (BioRad Laboratories, Inc.). The resulting membrane was western blotted against phosphoeIF4E according to the manufacturers specifications (Cell Signaling Technologies).
Briefly, the membrane was blocked in blocking buffer (see recipes) for 1 hour at room
temperature. The membrane was then rinsed briefly in TBS/T (see recipes) and then
incubated with the phospho-specific eIF4E antibody at a 1:1000 dilution in primary
dilution buffer (see recipes) overnight at 4°C under gentle rocking. The membrane was
then washed 3X5 minutes in TBS/T and incubated in the secondary HRP conjugated
antibody at a dilution of 1:10,000 in blocking buffer for 1 hour at room temperature
under gentle rocking. The membrane was then washed 5-7X5 minutes in TBS/T. The
membrane was then incubated for 5 minutes in SuperSignal (Pierce) and drained.
Following this the membrane was visualized on an imager (AlphaInnotech). After
imaging, the membrane was washed 3X5 minutes and then incubated with an antibody
against the total eIF4E at a dilution of 1:1000 in primary dilution buffer. The membrane
was washed as before and incubated with the secondary HRP conjugated antibody as
previously indicated. The membrane was revisualized to detect the amount of total
eIF4E. To confirm the validity of the phospho-specific antibody CHO cells were plated
as described previously and stimulated with 20% FBS prior to analysis.
4E-BP1 phosphorylation studies and antibodies
CHO cells were plated at 4X105 cells/well in 6 well plates the day prior to
infection. On the day of infection, the monolayers were washed 2X with PBS and
inoculated with either WSN (MOI=10) or a mock inoculum. Following a 1 hour
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adsorption incubation at 37°C, the monolayers were washed 1X with PBS and replaced
with fresh media. At times 4, 8, 12 and 16 HPI the monolayers were washed 1X with
PBS and lysed in 100µl of SDS-PAGE loading buffer. Twenty µL of each lysate were
run on a 12% SDS-PAGE gel and transferred to a PVDF membrane according to the
manufacturer’s specifications (Bio-Rad Laboratories, Inc.). The resulting membrane
was then western blotted against with phospho-specific antibodies directed against
either the S-65 or T-70 phosphorylation sites (Cell Signaling Technologies) as indicated
earlier. Following image analysis, these blots were reprobed against the total 4E-BP1
(Cell Signaling Technologies) in a manner similar to that indicated previously.
For MDCK cell 4E-BP1 phosphorylation studies, cells were plated at 2X105
cells/well the day before infection. The cells were then infected with WSN (MOI=10) or
a mock inoculum as stated previously. Samples were lysed as stated previously at 4
and 8 HPI and analyzed for phosphorylation of 4E-BP1 as before. However, in this
case rather than computer imaging, X-ray films were exposed and developed on a
developer (Kodak).
Effect of transfection on CHO infection efficiency
The day before transfection, CHO cells were plated at 1X105 cells/well on glass
cover slips in 24 well plates. The cells were either transfected as before with
pcDNA3.1+ control vector + transfection reagent or left untreated as a control. Eight
hours post transfection, the cells were washed 1X with PBS and infected with
approximately 10 TCID50 units per cell of WSN as stated previously. Nine HPI the cells
were fixed in 100% methanol at –20°C for 15 minutes. The cover slips were removed
from the plates, glued to glass slides and stored at –20°C. For staining the slides were
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incubated in a FITC-conjugated anti-influenza A virus NP antibody (Virostat) at a dilution
of 1:5 in PBS and incubated in a moist chamber at 37°C for 1 hour. The slides were
then washed 1 X 5 minutes in PBS. The slides were then washed 1 X 5 minutes in PBS
+ evans blue followed by an additional 5 minute wash in fresh PBS. Cover slips were
mounted onto the slides using mounting media (Invitrogen Corporation) and they were
then stored at –20°C until viewed on a confocal microscope (Leica).
Statistics
T-tests, ANOVA, two-way ANOVA, and regression analysis and end point
significance were performed using SAS software (SAS Institute, Inc.).
Recipes
Phosphate buffered saline (PBS) (10L)
NaCl.................................. 80g
KCl .................................... 2g
KH2PO4 ............................. 1.2g
Na2HPO4 ........................... 9.1g
MiliQ water........................ to 10L
Physiological saline
NaCl.................................. 8.5g
MiliQ water........................ 1L
Packed chicken red blood cells (CRBC)
1. Collect chicken blood in a heparinized tube
2. Spin at 500 X G for 5 minutes at 4°C
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3. Remove the supernatant and resuspend in 10mL physiological
saline
4. Repeat steps 2 and 3
5. Remove supernatant and resuspend in 10mL of PBS
6. Spin at 500 X G for 20 minutes at 4°C
7. Remove supernatant and store at 4°C for up to 1 week
0.5% Chicken red blood cells (CRBC)
PBS (cold)......................... 50mL
Packed CRBC................... 0.3mL
Store at 4°C for 1 week
SDS-PAGE Running buffer (10X)
Tris base ........................... 30g
Glycine.............................. 144g
SDS .................................. 10g
MiliQ water........................ to 1L
Dilute 1:10 in miliQ water before use
Transfer buffer (10X)
Tris base ........................... 30g
Glycine.............................. 144g
MiliQ water........................ to 1L
Transfer buffer (working solution)
Transfer buffer (10X) ........ 100mL
Methanol ........................... 200mL
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MiliQ water........................ 700mL
Tris buffered saline TBS (10X)
Tris base ........................... 24.2g
NaCl.................................. 80g
MiliQ water........................ to 1L
(Adjust pH to 7.6 with HCL)
TBS + tween-20 (TBS/T) (1L)
TBS (10X) ......................... 100mL
MiliQ water........................ 900mL
Tween-20.......................... 1mL (equals 0.1%)
Blocking buffer
TBS (10X) ......................... 15mL
MiliQ water........................ 135mL
Nonfat dry milk.................. 7.5g
Tween-20.......................... 0.15mL (equals 0.1%)
Primary antibody dilution buffer
TBS (10X) .................................... 2mL
MiliQ water................................... 18mL
Bovine serum albumin (BSA)....... 1g
Tween-20..................................... 0.02mL (equals 0.1%)
Evans blue stock solution (2%)
2g evans blue in 100mL miliQ water
PBS + evans blue
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PBS................................... 300mL
Evans blue stock solution 0.3mL
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